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ABSTRACT 
 
Fundamental and Applied Studies of Electrochemical Methods for the Detection of 
Polyanion and Polycation Species  
 
by 
 
Andrea K. Bell-Vlasov 
 
Chair: Mark E. Meyerhoff 
 
 Potentiometric polyion sensors have many advantages and potentially important 
applications in the clinical/biomedical field.  Although conventional polyion sensors have 
been applied for detecting a wide range of polyionic analytes and enzymes that can 
depolymerize these species, they are essentially single-use devices, which limit broader 
applications, especially in automated flow-through analytical methods.  Within the last 
ten years, reversible chronopotentiometric polyion sensors (pulstrode) have been 
developed to overcome the limitations of the single-use devices.  In this thesis, further 
mechanistic studies and a quality control application of the single-use polyion sensors are 
examined, and additional development and novel applications of the newer pulstrode type 
polyion sensor systems are reported. First, the mechanism of potentiometric response of 
the single-use polyanion sensor is re-examined.  Using fractionated heparin void of low 
molecular weight heparins, the extraction and transport of macromolecular heparin into 
	   xvii	  
the polymer membrane of the sensor as a complex with tridodecylmethylammonium ion 
is reconfirmed, and diffusion coefficients of 2.7x10-9 cm2s-1 ± 0.27 for the complex are 
found.  Such polyanion sensors are then employed in detecting the presence of 
oversulfated chondroitin sulfate (OSCS) contaminant/adulterant in commercially 
available lots of heparin from Baxter, Inc.   Results using the polyanion sensor are found 
to correlate 100% with NMR data.   
 In the second portion of this research, a reversible pulstrode type polyion sensor is 
applied to study three different systems.  The pulstrode is utilized for the first time as a 
detector in flow-injection analysis (FIA).  The system is capable of measuring both 
polycations and polyanions in the 10-100 µg/mL and 40-200 µg/mL range, respectively, 
using the same sensor/membrane formulation with a sample throughput of up to 20 
samples/h.  The pulstrode is also employed in monitoring enzymatic reactions, where 
hexametaphosphate/acid phosphatase is used as a model substrate/enzyme system.  The 
rate of reversal in potentiometric polyanion signal indicates the rate of digestion of the 
polyanionic substrate, hexametaphosphate, and hence the amount of enzyme activity 
present.  Lastly, the pulstrode’s parameters (current pulse magnitude, etc.) are optimized 
to improve the detection limits in the application of this sensor to detect high charge 
density contaminants in heparin preparations, achieving an LOD of 2 wt% for pentosan 
polysulfate in heparin.           
	   1	  
CHAPTER 1	  
INTRODUCTION 
 
 
1.1 Ion-selective Electrodes 
 Polymeric membrane-based ion-selective electrodes (ISE) are commonly used to 
monitor the activities/concentrations of biologically important ions, such as Na+ and K+, 
and are also now used to measure pH.  Such devices are based on incorporating lipophilic 
ion-exchangers and/or ionophores within the organic membranes that are capable of 
selectively interacting with target anions or cations within the sample phase.  The 
predictable and reproducible responses of ISEs, along with their ability to make 
measurements in turbid solutions (e.g., whole blood) make these sensors ideal for rapidly 
determining concentrations of biologically important analyte ions.1-4  
ISEs monitor ion activity by measuring the potential difference between two 
membrane interfaces: the inner solution/membrane interface and the sample/membrane 
interface.  The ISE membrane potential of the inner solution/membrane interface is 
considered constant since the ion activity within the inner filling solution of the electrode 
does not change.  Therefore, the overall membrane potential is a function of the phase 
boundary potential developed at the sample/membrane interface that is dependent on the 
equilibrium of the analyte ion across that interface with components in the membrane 
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(e.g., ionophore) (Figure 1.1).  This membrane potential is added with the other potentials 
that occur in series for the measurement cell, including the potential of the inner 
reference electrode (e.g., Ag/AgCl) and the external reference electrode.  The overall cell 
potential that is measured is mathematically described by the Nernst equation: 
                                                       
€ 
E = K + RTzF lna  
where E is the membrane potential, K is the sum of all constant components of the overall 
cell potential, a is the target analyte activity in the sample phase, R is the gas constant, T 
is temperature, F is Faraday's constant, and z is the charge of the target analyte ion.  Data 
outputs from ISEs are voltage per activity/concentration, and should exhibit a Nernstian 
slope equal to RT/zF = 59.2 mV/z.2  Therefore, as the analyte charge increases, the 
system’s sensitivity to small concentration changes diminishes (i.e., the Nerstian slope 
decreases).   
                     	  
Figure 1.1. Scheme of ion-selective membrane.  Target ion activity is constant within the aqueous 
inner filling solution phase: therefore, the membrane potential changes in response to change of the 
target ion concentration in the aqueous sample phase. Note that R-/+ may also be an ionophore. 
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 Based on the general ISE response mechanism, which requires the target ion to 
participate in an equilibrium reaction across the membrane/sample interface, it was once 
thought that larger multi-valent polyion analytes could not be measured because the 
observed signal would be too small to be analytically useful, and the chances that such 
larger ionic species could actually be extracted and interact via an equilibrium process 
with lipophilic species (ion-exchangers and/or ionophores) within the polymeric organic 
phase was considered unlikely.  However, optimization and development of ISE 
membrane compositions in the early 90’s led to the development of the first polyion 
sensors, a breakthrough that yielded unexpectedly large EMF signal changes to low 
concentrations (e.g., µg/ml) of higher molecular weight polyionic analytes (e.g., heparin, 
pentosan polysulfate, protamine, etc.).   
1.2 Potentiometric Polyion Selective Electrodes 
 Polyion selective sensors were pioneered by the Meyerhoff group in the early 90’s 
and have been employed in variety of applications including heparin detection in whole 
blood (its first application),5-8 monitoring enzymatic activity,9 monitoring protamine 
assays,10 determining carrageenan in food products,11 and its most recent application, 
detection of toxic, high charge density polyanionic contaminants (i.e., oversulfated 
chondroitin sulfate) in commercially available heparins.12  
 Heparin is a polydisperse glycosaminoglycan (GAG) with a charge density of ~ -
70.13  It is an anticoagulant which is administered during procedures such as open-heart 
surgery14 or used therapeutically for conditions like deep vein thrombosis.15  It is 
important to monitor polyanionic heparin due to its association with dangerous side 
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effects such as hemorrhaging/bleeding.16  The most common method used to monitor 
heparin activity is the Active Clotting Time (ACT) assay.  The ACT assay measures the 
time it takes for whole blood to clot before, during, and after surgeries like cardio-
pulmonary bypass (CPB).17  Although ACT is commonly used in clinical settings, it has 
slow response times, lacks specificity and yields results which are easily perturbed by 
many variables (e.g., patients with lupus, hypothermia, factor deficiencies, and diseases 
that impact platelet count and function like thrombocytopaenia).18-20  However, polyion 
sensors can monitor heparin in whole blood and provide rapid measurements with good 
selectivity, avoiding the shortcomings of ACT.5-8  In addition, protamine, the antidote for 
heparin (when it forms a strong, neutral complex with heparin), can also be monitored 
indirectly with the heparin sensor10 via heparin titration or monitored directly with a 
protamine sensor (+20/molecule charge), where the polymeric membrane is modified (in 
comparison to the heparin sensor) to give the sensor protamine selectivity.21    
During the development of this sensor, efforts were made to determine the 
optimal membrane composition for the detection of heparin, which has a charge density 
of ~ -70.  Various ion-exchangers were doped into plasticized polymeric membranes, and 
the resulting EMF response to heparin was examined.6  It was determined that 1.5 wt% 
tridodecylmethylammonium chloride (TDMACl) doped into a poly(vinyl chloride) 
(PVC) membrane plasticized with dioctyl sebecate (DOS) provided the optimal heparin 
response.  Heparin and other polyanions make strong cooperative ion-pairs with TDMA+ 
species, displacing chloride, and therefore enhance membrane polyion selectivity over 
other simple anionic species such as Cl-.  Although sensors doped with ion-exchangers 
(in the absence of ionophores) should exhibit responses to anions predicted by the 
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Hofmeister series2 (e.g., based on lipophilicty of anions), large super-Nernstian responses 
were observed in the presence of very hydrophilic heparin when the sensor was not 
conditioned in the target analyte (e.g., heparin) prior to measurements.   
Efforts were also made to improve detection limits by optimizing the polymer: 
plasticizer ratio.7  Changing the ratio to 2:1 polymer to plasticizer improved the detection 
limits (unlike classical ISEs, which typically have a polymer:plasticizer ratio of 1:2).  
This more rigid membrane composition limits diffusion of heparin into the membrane, 
causing a large EMF change at the membrane/sample interface at even lower 
concentrations of heparin in the sample.  Two mechanisms were found to fully describe 
the response behavior of this sensor: (1) the equilibrium response and (2) the quasi-steady 
state response.7    
1.2.1 Equilibrium Response 
In the presence of large concentrations of polyanion (assuming the membrane has 
not been conditioned in the target polyion and only in physiological phosphate buffer) or 
for very long conditioning/equilibration times in buffer containing the polyanion, Cl- ions 
in the membrane phase will be fully displaced at the sample/membrane interface by the 
target polyion analyte.  A large decrease in the phase boundary potential of the 
sample/membrane interface occurs due to the association of the polyanion with the 
TDMA+ sites within membrane.  This initial potential change saturates immediately in 
the presence of such high concentrations of the polyion to the so-called equilibrium 
response, which is not analytically useful (e.g., for heparin, <-1 mV/decade).  However, 
the overall potential change is calculated by subtracting the baseline potential from the 
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equilibrium potential, and this value distinguishes polyions based on their difference in 
charge density since the overall potential change increases proportional to the charge 
density.8  This is due to the thermodynamics of extraction of the different polyanions to 
form ion-pairs with the TDMA+ species.  Figure 1.1 demonstrates the different responses 
observed to chondroitin sulfate (CS), heparin, and dextran sulfate (DS), where the charge 
densities increase in the order of CS < heparin < DS.   
            
 
This phenomenon allowed Wang et al. to demonstrate the feasibility of detecting 
oversulfated chondroitin sulfate (OSCS),12,22 a lethal and high charge density 
contaminant that was found in commercially available heparins in 2008 (by NMR and 
capillary electrophoresis), and caused many deaths.  Indeed, in the simultaneous presence 
of two polyanions with different charge densities, the sensor response is governed by the 
Figure 1.2. Overall potentiometric responses to (A) chondroitin sulfate, (B) heparin, and (C) dextran 
sulfate at 1 mg/ml.  Approximate ∆EMF for each polyion are as follows; (A) ~-35 mV, (B) ~-50 mV, 
and (C) ~-100 mV.  Measurements were made in separate solutions in a background of 120 mM NaCl 
in phosphate buffer, pH 7.4. 
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larger charge density analyte because the cooperative ion-pair formation 
thermodynamically favors analytes with higher charge densities.  
Although the heparin sensor is an accurate, robust, and reproducible method of 
detecting heparin and other high charge density polyanions, it is a single-use device.  Due 
to the strong cooperative ion-pairing between the polyanions and the TDMA anion-
exchanger, polyanion dissociation is extraordinarily slow, and thus the sensor is rendered 
incapable of repeated use.  However, within the last ten years, reversible polyion sensor 
technology has been developed to address these issues.24-27   Additional discussion of this 
topic can be found in Section 1.3, below. 
1.2.2 Quasi-Steady-State Response 
The useful analytical working range of the polyion sensor is limited over a 
relatively narrow concentration and is dictated by a non-equilibrium response 
mechanism, which is best described as a quasi-steady-state EMF response.7  At very low 
concentrations, the polyion is pulled into the membrane to form a complex, or 
cooperative ion-pair, with the ion-exchanger.  The target polyions diffuse from the 
sample phase into the polymer membrane surface, thermodynamically driven by 
polyion/ion-exchanger complex formation.  While extraction of polyion from the sample 
phase is occurring, the cooperative ion-pair simultaneously diffuses into the bulk of the 
membrane at a slower rate (i.e., the rate limiting step) owing to the small diffusion 
coefficient of such complexes within the highly viscous polymeric phase.  A steady-state 
phase boundary potential at the membrane/sample interface can be observed when the 
rate of polyion mass transport to the surface of the polymer membrane is equal to the rate 
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of the polyion-TDMA complex moving into the bulk of the polymer membrane phase.   
Such steady-state response is analytically useful to determine concentrations of the 
polyion.  However, with extended time, no matter what concentration of polyion is 
present in the sample, a gradual drift down in the EMF values to the equilibrium response 
(i.e., over a ~24 h period after sample introduction) is observed (Figure 1.2).  As the 
polyion/ion-exchanger complex migrates across the membrane, it will eventually break 
through to the backside interface, and a reversal of EMF signal is observed (changes the 
phase boundary potential at the inner solution/membrane interface).  Recent studies, 
however, have questioned whether a large heparin/TDMA complex is capable of this 
membrane bulk-diffusion.28-32      
                      
Figure 1.3. Sensor response to concentrations of heparin and OSCS within the analytical working 
range of the polyion sensor.       
           
1.2.3 Transport Studies          
Since the quasi-steady-state model is highly dependent on the polyanion 
extraction into the membrane, heparin transport studies were conducted during its early 
development to confirm this mechanism.  Transport studies involved equilibrating 
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membranes for long time periods while monitoring the membrane potential response to 
heparin as it was extracted into the membrane (Figure 1.3) as well as 
spectrophotometrically monitoring fluorescein-labeled heparin with multiple layers of 
polyion sensing membranes.7  
                
Figure 1.4. Polyanion extraction from the sample phase into the membrane phase.  (A) Polyanion 
added to the sample phase and (B) Polyion extraction into the membrane phase to make a 
cooperative ion-pair with TDMA+, where the phase boundary potential, ∆Φ pb, at the 
sample/membrane interface decreases. 	  
Recent literature, on the other hand, suggested that the response mechanism used 
to describe the sensor was not completely valid, as heparin may not be capable of 
penetrating the membrane in this fashion.28-32  In these recent studies, voltammetry and 
amperometry were employed to measure unfractionated heparin.  It was suggested that 
high molecular weight (HMW) heparin might only adsorb to the surface of the membrane 
with limited extraction into the membrane phase.  Amemiya and co-workers studied 
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heparin transport across a liquid/liquid interface of two immiscible electrolyte solutions 
(ITIES) via voltammetry.28-30  Since heparin is very polydispersed, this study concluded 
that only low molecular weight (LMW) heparin could penetrate the organic phase.  
Similar conclusions were made by Samec and co-workers, who reported amperometric 
studies that employed glassy carbon electrodes coated in plasticized membranes doped 
with different ion-exchangers.31,32  These recent studies suggest that the reversal in 
potentiometric signal reported by Meyerhoff and co-workers might have been a result of 
LMW heparins being extracted into the membrane, while HMW heparins were only 
adsorbed to the surface.  These reports prompted a re-evaluation of the heparin sensor 
mechanism,33 as described extensively in Chapter 2 of this thesis.     
1.3 Chronopotentiometry and Polyion Sensitive Pulstrodes 
A chronopotentiometric method for reversible detection of polyions was 
pioneered by the Bakker group in the early 2000’s.23-26  In the early stages of its 
development, this reversible method was used to determine concentrations of Na+ and 
K+.27  The experimental set-up consisted of three conventional electrodes: working, 
counter, and reference (Figure 1.4).   
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Figure 1.5. Conventional three-electrode set-up for pulstrode: the working electrode houses the 
sensing membrane and the platinum counter electrode and a double-junction reference electrode 
complete the electrochemical cell.   
 
The working electrode functioned as the sensing membrane, which was doped 
with a Na+ ionophore and a lipophilic supporting electrolyte.  The sensing membrane had 
no intrinsic ion-exchange properties.  A typical measurement consisted of a two-pulse 
sequence: a galvanostatic (current) pulse, employed to polarize the membrane and induce 
an ion-flux towards the sample/membrane interface, and a potentiostatic pulse, designed 
to depolarize the membrane and regenerate the original phase boundary at the 
sample/membrane interface by expelling ions pulled in during the current pulse.  
Potentiometric data was collected during the current pulse.  The galvanostatically-
controlled system is tunable and allows for adjustment of several parameters that cannot 
be controlled in conventional potentiometric experiments.  The current magnitude 
regulates the concentrations of extracted ions and the observed selectivity.  For example, 
in these early experiments, potential response to Na+ is observed over K+ since the sensor 
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is doped with a sodium-selective ionophore.  This experiment is carried out using lower 
current magnitudes (-1 to -15 µA) where the uptake of Na+ is assisted by the ionophore as 
well as the current.  In contrast, if the current magnitude exceeds -25 µA, the sensor 
response is no longer assisted by the ionophore, and the potential response to K+ is 
observed due to the greater lipophilicity of K+ over Na+.  In addition to controlling 
selectivity, the type of ion (cation vs. anion) that is extracted is also controlled by the 
direction of current so that cations and anions can be measured with the same membrane 
formulation (though not necessarily the formulation mentioned above).  Therefore, the 
magnitude and direction of ion fluxes (induced by the current pulse) across the ion-
selective membrane is another factor that can be controlled.   
The innovation of implementing a galvanostatic pulse allows for greater 
flexibility in experimental conditions without reformulating the sensor membrane, as is 
required in classical potentiometry and the non-classical polyion sensors.  Most 
significantly, the development of this chronopotentiometric method directly addresses the 
problems associated with irreversible single-use potentiometric polyion sensors, and is a 
springboard towards future advances in polyion sensing (see below). 
1.3.1 Pulstrode for Polycation Sensing 
 In 2004, modifications were made to the previous system reported by Bakker and 
co-workers for the detection of the polycation protamine.24  An additional third pulse was 
added to the original two-pulse sequence, providing a sequence order as follows: a 1.0 s 
galvanostatic pulse, a zero-current open-circuit pulse of 0.5 s, and a 15 s potentiostatic 
pulse.25  The additional open-circuit pulse measurement can be directly compared to open 
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circuit potentiometry.  The data is sampled at the end of the open circuit pulse in contrast 
to the original method and provides measurements without the undesirable iR drop 
observed in potential data collected during the current pulse.  It should be noted that 
during a typical measurement, raw data is collected for both current and potential during 
all three pulses (Figure 1.5A and 1.5B).          
 
Figure 1.6. (A) Current-time behavior and (B) potential-time behavior, where I is the galvanostatic 
pulse, II is the open circuit zero current pulse where data is sampled and averaged over the last 10% 
of the pulse period, and III is the potentiostatic pulse.  (C) Structures of lipophilic salt species used to 
prepare polyion sensing pulstrode membrane. 	  
            Another major sensor modification pioneered by Bakker and co-workers was 
replacing the sodium selective ionophore and lipophilic supporting electrolyte with a 
dinonylnaphthalene sulfonate (DNNS-): tetradodecylammonium (TDDA+) salt (Figure 
1.5C).  Protamine (an arginine rich low molecular weight polycationic protein that 
neutralizes heparin activity) makes a strong cooperative ion-pair with DNNS-, and when 
a cathodic current is pulsed, the sensor displays protamine selectivity.  This cathodic 
current pulse applied to the sensor polarizes the ion-exchanger salt so that the DNNS- 
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migrates to the sample/membrane interface, causing the interface to become a cation-
exchanging interface.  During the zero current pulse, DNNS- can then exchange small 
inorganic ions, such as Na+, for protamine, since protamine is the more preferred ion for 
the cooperative ion-pairing reaction with the DNNS- species.  Potentiometric data 
obtained using this method, termed ‘pulstrode’, is collected as an average of the last 10% 
of the open circuit EMF measurement data, in contrast to the original set-up, where 
potentiometric data was collected during the current pulse (Figure 1.6).  These 
differences distinguish the two methods that use the same instrument: the former is called 
chronopotentiometry and the latter method is termed ‘pulstrode’ by Bakker and co-
workers.  Chronopotentiometry is useful for monitoring changes at concentrations in the 
millimolar range, whereas the pulstrode configuration allows for measurements in 
systems where the membrane resistance is large (no iR drop observed during open-circuit 
measurement period) and/or for measurements in lower concentration ranges (in respect 
to cations/polycations).24    
             
Figure 1.7. Membrane configurations during each pulse of pulstrode system; Pulse I denotes the 
direction of the ion-flux under an anodic current pulse, Pulse II shows the membrane during open 
circuit measurement where the ion-exchanger forms a complex with the target analyte, and Pulse III 
demonstrates the voltage pulse where ions that were pulled in during Pulse I are expelled.  Ion 
notations are as follows: Pz- is polyanion, A- is the interfering ion (Cl-), and I+ is the counterion (Na+), 
R+ is the anion of the lipophilic ion-exchanger salt (TDMA+) and R- is the cation of the lipophilic ion-
exchanger salt. 
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1.3.2 Pulstrode for Polyanion Sensing 
 The pulstrode system is also capable of measuring polyanions in addition to 
polycations such as protamine, if a directional reversal of applied current during the 
galvanostatic pulse is implemented.  The ion-exchanger salt used in the pulstrode is 
effective since protamine can form a strong cooperative ion-pair with DNNS- when 
cathodic current is applied.  However, although the DNNS- contained within the 
pulstrode membrane can form a cooperative ion-pair with polycations such as protamine 
when cathodic current is pulsed, for polyanion sensing with the same membrane, the 
cation of the partner ion-exchanger salt must be able to make a strong cooperative ion-
pair with the target polyanion when anodic current is pulsed.  In 2010, Gemene et al. 
reported successful detection of glycosaminoglycans (GAGs) (e.g., CS, heparin, OSCS, 
pentosan polysulfate (PPS)) with a pulstrode type sensor.  The ion-exchanger salt had 
been changed to a DNNS-/ TDMA+ salt (see Figure 1.3 for structure of TDMA+) in order 
to improve the observed response when measuring these specific GAGs.34  During the 
development of the single-use heparin sensor in the 90’s, many quaternary ammonium 
species were examined and their ion-exchange/ion-pairing properties assessed with 
respect to heparin detection.  Very little response to heparin was observed for TDDA+ 
doped membranes, due to the quaternary-N+ being sterically hindered by the four long 
alkyl chains of the molecule.  On the other hand, TDMA+ has only three long alkyl chains 
and one methyl group; consequently, the quaternary-N+ is more easily accessible for 
heparin to form a strong cooperative ion-pair.  The use of TDMA+ as a partner to DNNS- 
has led to the development of other pulstrode applications.35 
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1.3.3 Chronopotentiometric Detection of Protamine:  Improving Detection Limits 
Protamine detection limits in physiological NaCl have recently been improved by 
reformulating the sensing membrane and monitoring the voltage during the current pulse 
instead of the zero-current open-circuit measurement period.35  In the developing stages 
of the pulstrode, the 1:1 molar ratio of the ion-exchanger salt was essential to obtain 
stable and reproducible measurements.  Great care must be taken in synthesizing the salt 
so that the 1:1 molar ratio is achieved.  Recently, a new ion-exchanger salt with a 2:1 
molar ratio of DNNS-: TDDA+ was reported.  In addition to modifying the ion-exchanger 
salt composition, a porous polypropylene membrane was utilized as a scaffold to hold the 
new ion-exchanger salt dissolved into a plasticizer.  This differs from the original 
formula, which incorporated the ion-exchanger salt into a plasticized polymeric 
membrane.  Essentially, the porous polypropylene allows for a much thinner membrane 
with very low resistance.  The original 1:1 TDDA/DNNS sensing membrane also had no 
intrinsic ion-exchange properties, as mentioned above, in contrast to the 100% molar 
excess of DNNS- in the 2:1 ratio of DNNS-: TDDA+, which is ion-exchanging, without 
the assistance of the pulse sequence.  The excess DNNS- forms a complex with protamine 
and the extra protamine inside the membrane now prevents interfering ions like Na+ from 
being extracted into the membrane during the current pulse by the law of mass action, 
and consequently decreases the detection limits in the presence of physiological NaCl.35   
Another major difference between this method and the polyion sensing pulstrode 
method is the data acquisition.  The potentiometric data is collected during the current 
pulse, and the length of this pulse is also extended beyond 1 s to ensure depletion of the 
target analyte.  In addition, the sequence of pulses is re-arranged: (1) open-circuit pulse, 
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(2) current pulse, and (3) potentiostatic pulse.  During the current pulse, the voltage is 
monitored and an inflection in signal is observed when the diffusion layer is depleted of 
the target analyte.  The time it takes for the inflection in signal to appear (transition time) 
increases as the target analyte concentration increases.  The magnitude of the current 
pulse can also be manipulated to alter the linear response of the sensor.  As the magnitude 
of the current increases, the linear range is shifted to larger concentrations.  Smaller 
current magnitudes are incapable of depleting the diffusion layer of the target analyte at 
high concentrations; an inflection point in the potentiometric data cannot be 
distinguished.  By increasing the magnitude of the current, larger concentrations of target 
analyte can be depleted, and a shift in linear range is observed.  This method has 
applications in monitoring protamine in whole blood and heparin indirectly by observing 
a decrease in concentration of protamine due to the neutral complex formed between 
heparin and protamine.36 
1.4 Statement of Research    
 In this dissertation, applications of existing and newer electrochemical detection 
methods of polyions are explored.  In Chapter 2, the mechanism of the previously 
developed single-use heparin sensor, based on heparin diffusion through the membrane, 
is re-examined in response to recent reports that suggest that heparin is only adsorbed to 
the surface of the membrane.  Electrochemical impedance spectroscopy is employed to 
monitor heparin diffusion into polyion sensing membranes.  Further, purified heparin is 
employed for these experiments to remove low molecular weight components.  Gel 
electrophoresis is utilized to visually confirm the molecular weight differences of 
fractionated, unfractionated, and low molecular weight heparins.  In addition to those 
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experiments, transport cells are used to monitor the EMF of membrane over a 72 h period 
as heparin is extracted into the membrane.  To validate the established mechanism, an 
equation, derived from Fick’s II law and the Nernst equation, is used to calculate the 
diffusion coefficients of heparin through membranes of various thicknesses.  The work in 
Chapter 2 was published in Electroanalysis (2012, 24, 53-59).  
 In Chapter 3, the biomedically relevant application of heparin sensors for the 
detection of high charge density species (i.e., OSCS) in real heparin samples is described.  
Heparin samples provided by Baxter, Inc. are analyzed and compared to NMR data (also 
provided by Baxter).  A 100% correlation between results from the heparin sensor 
method and the reported NMR data is found. 
 Chapter 4 focuses on the use of the reversible pulstrode sensor as a detector in a 
flow-injection analysis (FIA) system.  The newer ion-exchanger salt (DNNS/TDMA) has 
the advantageous potential ability to measure both polycations and polyanions with the 
same sensor and the same membrane formulation simply by changing the direction of 
current.  A cathodic current is applied to measure polycations and anodic current is 
applied for polyanion detection.  In contrast to the single-use sensors, the ability of the 
pulstrode system to regenerate the initial state of the membrane allows for system 
automation.  These two advantages permit pulstrode functionality as a detector in FIA.  
This method has applications in monitoring enzymatic activity and has higher throughput 
capabilities, compared to the static mode (absence of flowing solution).  Both protamine 
and heparin are measured and used to demonstrate this new concept.  Experiments are 
carried out to determine the stability and sensor reproducibility in the flow-injection 
mode.  Based on protamine/heparin titration measurements in physiological NaCl 
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concentrations, a possible application for monitoring heparin in whole blood is suggested, 
although such blood experiments have not yet been optimized for this system.  This 
subject is discussed in more detail within Chapter 7.  The research in Chapter 4 was 
published in Analytical Chemistry (2014, 86, 4041-4046). 
 Chapter 5 demonstrates the application of the pulstrode device in monitoring 
enzymatic reactions.  The degradation of the substrate hexametaphosphate by acid 
phosphatase is used as a model system.  The potential induced by the substrate is 
monitored and the addition of the enzyme induces a reversal in the signal indicative of 
the degradation of the substrate.  The enzymatic reaction rate is calculated from the 
slopes in the EMF reversal during the first two min after injection of the enzyme while 
the rates of reaction increase as the activity of the enzyme increases.  The effects of 
adding enzyme inhibitor are also examined.  A decrease in enzyme activity, as the 
concentration of enzyme inhibitor increases, is observed and represented by a slower 
reversal in EMF signal for one given enzyme activity level. 
It should be noted that single-use polyion sensors have been successfully 
employed for enzyme assays previously.9,10  Polyion digestion in enzymatic reactions is 
easily observed upon measurement with potentiometric polyion sensors.  The main 
limitation of single-use polyion sensors is their irreversible nature.  When these sensors 
are employed in monitoring enzymatic reactions, a change in potential towards the 
baseline is observed, but the signal never fully reaches the baseline.  This may be due to 
the polyion-TDMA+ pair diffusing further into the membrane, where a small proportion 
of these pairs may not be accessible for enzymatic cleavage.  Consequently, as the 
dissociation of the cooperative ion-pair is slow, the sensor cannot be used twice.  
	   20	  
Therefore, the pulstrode addresses the problem of irreversibility of the single-use sensor 
in this application. 
In Chapter 6, the use of the pulstrode for the detection of higher charge density 
species as contaminants in heparin is investigated.  Although the detection of high charge 
density species in heparin with detection limits as low as those reported for single-use 
polyion sensors12 (0.5 wt% OSCS in heparin) have yet to be achieved due to the pulstrode 
system’s kinetics (explained in more detail in Chapter 6), optimization of system 
parameters including length of current pulse, length of open-circuit pulse, and magnitude 
of current pulse, are explored.  Pentosan polysulfate (PPS) is used as a model for high 
charge density species doped into heparin preparations and detection limits of this species 
in a heparin background are determined.   
In Chapter 7, conclusions, along with plans for future work, are presented.  
Moreover, applications for a reformulated membrane for reversible polyion sensors and a 
different data acquisition method, as well as further applications for the pulstrode system 
coupled with FIA are discussed.  
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CHAPTER 2 
REVISITING THE RESPONSE MECHANISM OF POLYMERIC MEMBRANE 
BASED HEPARIN ELECTRODES 
2.1 Introduction 
A series of studies carried out by this research group nearly 2 decades ago focused 
on developing a simple potentiometric sensor to monitor levels of the anticoagulant 
heparin in whole blood.1-4  It was found that a plasticized polymer (PVC) membrane 
doped with tridodecylmethylammonium chloride (TDMACl) could yield significant and 
analytically useful EMF response to heparin.  The heparin response was attributed to the 
ability of the TDMA+ cationic sites in the membrane to form a strong cooperative ion-
pair with heparin, and extract heparin species into the membrane phase.4  The overall 
theory for the observed potentiometric response was developed based on two different 
response regimes to heparin: 1) the equilibrium potentiometric response at high 
concentrations of heparin; and 2) the quasi non-equilibrium steady-state response that 
occurs only at low concentrations of the polyanion.  The equilibrium response is induced 
using high concentrations of heparin (e.g., >1 mg/mL) and a rapid anion exchange takes 
place at the sample/membrane interface (Cl- is exchanged for heparin).  The surface of 
the membrane reaches equilibrium with the sample quickly and the response can be 
predicted by the Nernst equation as applied for a polyionic species with a large negative 
charge, e.g. -70 (slope of < 1 mV/decade).  A large change in potentiometric signal (ca. -
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50 mV) is observed initially to any added heparin in this higher concentration region and 
is due to a voltage difference in phase boundary potential between the front and backside 
of the membrane.  This voltage difference is caused by a change in charge separation that 
is induced when the highly negative charge of heparin (ca. -70) interacts with the 
positively charged TDMA+ in the membrane phase with a very favorable free energy 
change of 11.42 kJ·mol-1z-1 (where z is the charge on the polyanion).4   
The sensor can also detect heparin via a significant EMF vs. concentration dose-
response at lower, clinically relevant levels of ~10-7 M1,3 (e.g., µg/mL range). At these 
low concentrations, the membrane response is described by a quasi-steady state non-
equilibrium mechanism.3  Here, the flux of polyanion toward the surface of the 
membrane must be equal to the rate of heparin diffusing (as a complex with TDMA+) 
into the bulk of the membrane away from the sample/membrane interface.  This response 
cannot be explained by the Nernst equation, since it only occurs under non-equilibrium 
conditions.  Indeed, changes in stirring rate3 or preparing rotating electrode type devices5 
can be used to alter the concentration range of heparin that can be detected.  However, no 
matter what experimental conditions are employed, after long equilibration times (~24 h), 
the expected full equilibrium response to heparin of ca. -1 mV/ decade is observed even 
at these lower concentrations.   
The quasi-steady state model is highly dependent on the extraction of heparin into 
the organic membrane phase.  Therefore, experiments were conducted to determine if 
extraction of heparin into the membrane does indeed take place via fluorophore labeled 
heparin as well as long-term potentiometric measurements.3  In one set of experiments, 
after the addition of high concentrations of heparin and the initial large negative EMF 
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response toward heparin is observed, after several hours, a reversal in the potentiometric 
signal occurs.3 At the time of these experiments, this reversal in the signal provided 
evidence of heparin extraction into the polymer films, since such a result should only 
occur if heparin reaches the backside of the membrane and changes the phase boundary 
potential at that interface, canceling the voltage change on the front-side of the 
membrane.  Further, using fluorescein labeled heparin and multi-layers of TDMACl 
doped plasticized PVC membranes that can be pealed apart after long-term equilibration 
with solutions containing heparin, the fluorophore labeled species were found to be 
present in the middle layers. Together, the results of these experiments suggested that 
heparin is likely extracted into the bulk of the organic polymer membrane phase.   
Recently, there have been other electrochemical studies that suggest that heparin 
does not diffuse into the bulk of organic phases containing lipophilic anion exchangers 
like TDMA+, but is only adsorbed at the aqueous/organic interface.6-10  These studies 
employ voltammetry/amperometry and examine a liquid/liquid interface of two 
immiscible electrolyte solutions (ITIES)8-10, or use glassy carbon electrodes coated with a 
plasticized PVC membrane.6,7  Samec and co-workers employed amperometry with a 
rotating glassy carbon electrode coated with an o-nitrophenyl octyl ether (o-NPOE) 
plasticized membrane doped with different anion-exchangers, including TDMA+, and a 
negligible response to heparin was observed.6  However, another study compared the 
response mechanism of membranes doped with hexadecyltrimethylammonium (HTMA+) 
and TDMA+ and reported that the amperometric response of the electrode coated with the 
membrane doped with TDMA+ was governed by the transport of the heparin complex 
with the TDMA+ inside the organic membrane phase, unlike the response of the 
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membrane doped with HTMA+, which was governed by adsorption of the heparin at the 
sample-membrane interface.7  Amemiya and co-workers employed voltammetric 
methods utilizing ITIES to analyze the response to heparin.10  It was concluded that 
unfractionated heparin could only be adsorbed to the surface of the organic phase at the 
sample/organic phase interface owing to the large and narrow current peak observed on 
the reverse sweep seen on the cyclic voltammograms. This was hypothesized to represent 
heparin being desorbed quickly at the liquid (aqueous)/liquid (organic) interface as the 
voltage was decreased.  In another study conducted by Amemiya and co-workers, 
Arixtra, a heparin mimetic with a molecular weight of only 1.5 kDa, was examined using 
the same techniques.9  Cyclic voltammograms showed a much smaller and broader 
current peak on the reverse sweep, which indicated that Arixtra was indeed extracted into 
the organic phase doped with TDMACl.9  The authors further concluded that if any 
heparin were to be extracted and diffuse into organic phases, it would likely be the low-
molecular weight species.   
It is possible that the data reported by Amemyia et al.8-10 as well as that originally 
reported by our group1-4 may have been a result of only low MW components of 
unfractionated heparin being extracted and transported.  In fact, unfractionated heparin is 
a heterogeneous mixture of sulfonated/carboxylated polysaccharides, with an average 
MW of 15 kDa, but with some fraction of species < 10 kDa.13,14  Therefore, in this paper, 
results of experiments to determine whether extraction/diffusion into/through plasticized 
PVC membranes containing TDMACl occurs when using a fractionated heparin 
preparation that contains predominantly high MW fractions are reported. The 
extraction/diffusion of the fractionated heparin is determined by two independent 
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methods; EMF reversal of the polymer membrane response and impedance spectroscopy 
of the heparin sensitive polymeric membrane used to prepare heparin/polyanion sensors. 
2.2 Experimental Section 
2.2.1 Membrane Preparation 
Membranes were made using 32.5% by weight poly(vinyl chloride) (PVC) (high 
molecular weight, Fluka), 66% by weight dioctyl sebecate (DOS) (Fluka), and 1.5% by 
weight TDMACl (26.2 mM) (Fluka).  This mixture was dissolved in distilled 
tetrahydrofuran (THF) (Fisher) to yield 100 mg/mL mixture, at volumes of 750 mL or 
1500 mL (yielding membranes of ca. 100 and 200 mm thick, respectively) that were cast 
into glass rings (25 mm diameter) and left to dry overnight.  Once the films were dry, 
they were conditioned in 50 mM NaCl for 24 to 48 h. 
2.2.2 Transport Cell Setup 
A single membrane was placed between two glass cells as part of the transport 
cell set-up (see Figure 1).  The donor solution contained 5 mg/mL heparin sodium salt 
(8.3 x 10-5 M using 15 kDa as average MW) in 50 mM NaCl background solution and the 
recipient cell also contained 50 mM NaCl.  Both cells contained a stir bar and a total 
volume of 6 mL.  A Ag/AgCl wire was placed inside each cell to monitor the 
transmembrane potential and connected to a Lawson Labs high impedance 8-channel 
voltmeter (Pennsylvania, USA). Each cell was stirred continuously throughout a 68 to 72 
h data acquisition period.  The thicknesses of the membranes were measured using a 
gravimetric method11 and these values were used in the final calculation of the heparin 
diffusion coefficients within the membrane phase. 
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Figure 2.1. Sketch of transport cell set-up.  Ag/AgCl wires were used for reference and working 
electrodes and cells were stirred throughout the data acquisition period.  The ISM is the ion-selective 
polymer membrane containing TDMACl that is sensitive to heparin. 	  
2.2.3 Impedance Measurements	  
For impedance measurements, the same membrane formulation and transport cell 
setup was used. The impedance spectra were recorded (EG&G instruments, model 6310) 
(Tennessee, USA) in the frequency range of 100 kHz to 1 Hz using a sinusoidal 
excitation signal with amplitude of 5 mV and DC potential used was the open circuit 
potential of the system. 
2.2.4 Sample Preparation 
Fractionated heparin samples were prepared using 10 000 molecular weight cut-
off tubes, centrifuged 3 times at 4000 rpm in a background solution of 50 mM NaCl, and 
re-diluted to a final concentration of 30 mg/mL.  The fractionation was confirmed by gel 
electrophoresis.  Fifty mL of 20% polyacrylamide gel (Fisher) was prepared with 300 mL 
of a 10% filtered ammonium persulfate (Fisher) solution and 30 µL of 
tetramythylethylenediamine (TEMED) (BioRad).  The gel was pre-run at 16 W for 30 
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min using a 1x Tris/Borate/EDTA (TBE) (Fisher) as the running buffer (pH 8.0).  
Heparin and enoxaparin (LMW heparin preparation) samples for gel were prepared as 
above at concentrations of 5 mg/mL.  A volume of 10 µL per lane for each sample was 
loaded onto the gel and was run at 16 W for 1.5 h.  The gel was stained for 30 min with a 
10x dilution of a mixture containing 0.1% (w/v) toluidine blue-o, 50% (v/v) methanol 
(Fisher), 10% (w/v) acetic acid (Fisher), 0.25% glycerol (Fisher), 4 mM Tris base 
(Fisher), and 0.1 mM EDTA (Fisher).  All appropriate preparations were prepared using 
Milli-Q grade deionized water (18.2 MW, Millipore Corp., Billerica, MA). 
2.3 Results and Discussion 
2.3.1 Theory 
The diffusion coefficient of ions in the polymer membrane can be assessed in a 
single ion-breakthrough experiment.  The EMF of a primary ion-free membrane (Note: in 
this case heparin is considered as primary ion, but the theory is also valid for any ionic 
species) is measured in a symmetrical electrochemical cell.  Initially there is a constant 
concentration of interfering ions on both sides of the membrane (i.e., chloride in the case 
of the TDMACl-based membrane).  After a stable membrane potential is reached, a high 
concentration of heparin or primary ion is injected into the sample solution side of the 
membrane.  By the application of the phase boundary potential model15 it can be proven 
that the slope of the reverse potential response curve only depends on the diffusion 
coefficient in the membrane and the thickness of the membrane.   
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The EMF value for a symmetrical electrochemical cell with negligible diffusion 
potential according to the phase-boundary potential model16,17 is given by the following 
expression: 
                                                                                                                (1)                                            
where EMF is the electromotive force, Ef and Eb are the phase boundary potentials at the 
front and the backside of the membrane.  Once the high concentration of heparin is 
added, the aqueous and outer (sample side) membrane phases equilibrate with the heparin 
via favorable anion-exchange, with heparin displacing chloride in the outer region of the 
organic membrane phase.  The phase boundary potential at the backside of the membrane 
is governed by the interfering ion (chloride) concentration until significant amounts of 
heparin reach the interface.  The aqueous phase boundary concentration of chloride 
within the internal solution is assumed to be constant for the entire course of the 
experiment due to the high concentration of chloride.  During the initial period of the 
experiment (first 1–2 h) the membrane phase boundary concentration of heparin on the 
backside is 0 until the first molecules of heparin reach that backside interface (when 
voltage starts reversal in Figure 2.2a).  Of course, the time required for the backside of 
the organic membrane phase to reach full equilibrium (with all chloride replaced by 
heparin) and the cell potential to level off (long time period), depends on the thickness of 
the membrane employed.  Further, given the favorable equilibrium constant for heparin 
ion-pairing with TDMA+ in the membrane phase, even after long periods of time (i.e., 30 
h) there is little or no heparin within the inner aqueous phase boundary layer (cJ (aq) = 0). 
€ 
EMF = E f − E
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Figure 2.2. a) Finite-element simulation of the potential response curve of a 100 µm membrane.  The 
membrane is conditioned in 50 mM interfering ion (chloride) solution.  At 0 h the primary ion 
(heparin) concentration is set to 5 mg/mL in the sample solution.  Arrows show the range used for the 
linear regression.  b) Concentration profiles of heparin in the membrane at 10, 20, 40, 80, 160, 320, 
640, and 1280 min after the addition of 5 mg/mL in the sample solution. 	  
  Applying these considerations, an equation where the only time dependent term is 
the interfering ion concentration (Cl- in this case) at the inner membrane boundary 
(backside) can be obtained, cJ (org). 
                                                        (2) 
where, kJ is a direct function of free energy of transfer of the interfering ion, cJ(aq), 
cJ(org) are the concentration of interfering ion in aqueous solution and the membrane, 
respectively.  The zJ is the valence of the interfering ion.  F, R, and T are the Faraday 
spectively. The zJ is the valence of the interfer ng ion. F,
R, and T are the Faraday constant, the gas constant and
the temperature, respectively. It is important to note that
the Equation 2 is also valid when an ionophore is present
in the ion-selective membrane (ISM), and the introduc-
tion of an equilibrium constant changes the E8 but the
only time dependent term remains the cJ(org) term.
Due to the diffusion of heparin through the membrane,
when it arrives to the backside of the membrane it repla-
ces the chloride. The total concentration of negatively
charged polyanions in the membrane is determined by
the concentration of the lipophilic cationic sites, TDMA+
(RT), in the membrane phase (RT=zIcI(org)+zJcJ(org)).
By applying the classical solution of Fick!s second law
[18] to the ISMs, cJ(org) can be expressed.
cJðorgÞ ¼ 4RTpzJ exp
$p2Dorgt
ð2dorgÞ2
 !
ð3Þ
where Dorg is th diffusion coeffici nt of the primary ion
(heparin) in the membrane; dorg and t are the membrane
thickness, and the time elapsed from the injection of the
primary ion, respectively. Thus, by plugging Equation 3
into Equation 2, the EMF can be described by a first
order equation as a function of time:
EMF ¼ Aþ B & t ¼ E0 þ RTzJF ln
4
p
RT
zJ
! "# $
þRTzJF ln
$p2Dorg
ð2dorgÞ2
 !
t
ð4Þ
The diffu ion coefficie t of th primary i n in the
membrane (Dorg) can be calculated from the slope of the
line (B).
Dorg ¼ $
4 & B & d2org & F & zJ
p2 & R & T ð5Þ
To validate this approach, we utilized a 1D finite-ele-
ment method to solve a coupled Nernst–Planck–Poisson
(NPP) differential equation system [19]. With this simula-
tion technique, it is possible to assess the time-dependent
behavior of ion-selective membranes in contact with
aqueous sample solutions containing heparin in a back-
ground of chloride anions. The simulated system consist-
ed of two aqueous diffusion layers and the ion-selective
m mbrane. The simulation grid consisted of 600 elements.
These elements were closely placed near the phase boun-
daries. The thicknesses of the diffusion layers and the
membranes were considered to be 100 mm. Relative per-
mittivities of water and the ISM were considered to be
80.1 and 10, respectively. The diffusion coefficient in the
Fig. 2. a) Finite-element simulation of the potential response curve of a 100 mm membrane. The membrane is conditioned in 50 mM
interfering ion (chloride) solution. At 0 h the primary ion (heparin) concentration is set to 5 mg/mL in the sample solution. Arrows
show the range used for the linear regression. b) Concentration profiles of heparin in the membrane at 10, 20, 40, 80, 160, 320, 640,
and 1280 min after the addition of 5 mg/L in the sample solution.
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constant, the gas constant and the temperature, respectively.  It is important to note that 
the Equation 2 is also valid when an ionophore is present in the ion-selective membrane 
(ISM), and the introduction of an equilibrium constant changes the E˚ but the only time 
dependent term remains the cJ (org) term.   
Due to the diffusion of heparin through the membrane, when it arrives to the 
backside of the membrane it replaces the chloride.  The total concentration of negatively 
charged polyanions in the membrane is determined by the concentration of the lipophilic 
cationic sites, TDMA+ (RT), in the membrane phase (RT=zIcI(org)+zJcJ(org)).  By 
applying the classical solution of Ficks second law18 to the ISMs, cJ (org) can be 
expressed by  
                                                                                          (3) 
where Dorg is the diffusion coefficient of the primary ion (heparin) in the membrane; dorg 
and t are the membrane thickness, and the time elapsed from the injection of the primary 
ion, respectively.  Thus, by plugging Equation 3 into Equation 2, the EMF can be 
described by a first order equation as a function of time:  
                                            (4) 
The diffusion coefficient of the primary ion in the membrane (Dorg) can be 
calculated from the slope of the line, B. 
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                                                                                                  (5) 
To validate this approach, we utilized a 1D finite-element method to solve a 
coupled Nernst–Planck–Poisson (NPP) differential equation system.19  With this 
simulation technique, it is possible to assess the time-dependent behavior of ion-selective 
membranes in contact with aqueous sample solutions containing heparin in a background 
of chloride anions.  The simulated system consisted of two aqueous diffusion layers and 
the ion-selective membrane.  The simulation grid consisted of 600 elements.  These 
elements were closely placed near the phase boundaries.  The thicknesses of the diffusion 
layers and the membranes were considered to be 100 µm.   Relative permittivities of 
water and the ISM were considered to be 80.1 and 10, respectively.  The diffusion 
coefficient in the aqueous phase and the membrane were 10-5 cm2s-1 and 2x10-9cm2s-1 
(Note: the diffusion coefficient for heparin was an estimate made based on the 
experimental data shown in Figure 2.5a).  The TDMA+ concentration was 26.2 mM, and 
the charges of heparin and chloride were considered as -70 and -1, respectively.  The 
forward heterogeneous rate constants across the interface for heparin and chloride were 
considered as 10-7 ms-1 and 2 x 10-5 ms-1; the backward heterogeneous rate constants 
across the membrane/solution interface for heparin and chloride were 10-9 ms-1 and 10-3 
ms-1.   
The NPP simulations confirmed that the assumptions used in the derivation of the 
Equation 5 were correct.  The backside phase boundary concentration of heparin in the 
membrane is zero during the initial portion (t=0–2 h) of the potentiometric curve (Figure 
2.2a).  Note that reversal in signal is observed after this initial time period since the 
€ 
Dorg = −
4⋅ B⋅ dorg2 ⋅ F ⋅ zJ
π 2 ⋅ R⋅ T
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diffusion layer inside the membrane continues to decrease in thickness and eventually 
heparin finally completely replaces chloride on the backside of the membrane phase, 
where the horizontal portion of the EMF response vs. time curve is observed (t >30 h). 
The Ef was constant during the entire course of the simulation.  The slope of the linear 
range is marked in Figure 2.2a and that range was used to calculate the diffusivity of ions 
through the membrane.  The slope obtained by linear regression was within 5% relative 
error of the value calculated with Equation 4. 
2.3.2 Impedance Spectroscopy 
The bulk resistance of an ion-selective membrane can be measured with 
electrochemical impedance spectroscopy experiments.20  The potentiometric technique 
provides useful information on the backside phase boundary concentrations, and 
therefore the arrival of heparin to the backside can be observed with the reversal of the 
potentiometric signal.  As a complementary method, impedance spectroscopy gives 
valuable information on the total concentration of heparin in the membrane.   
Initially, the membrane is filled with chloride anion as the counter ion of TDMA+.  
During the experiment, the negatively charged heparin replaces the chloride due to its 
higher preference by the ISM (formation of ion-pair with TDMA+).  The total bulk 
resistance of the membrane under steady-state conditions is given by the following 
formula:21  
                                                                                              (6) 
€ 
Rm =
dorgRT
AF 2
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where A is the membrane area.  From the classical solution of Ficks Law18 it can be 
shown that the total resistance of the membrane changes in time according to the 
Equation 7: 
                                                (7)  
where Rmin is the initial resistance when the membrane only contains chloride as 
counteranions and Rmax is the steady-state resistance when heparin exchanged the 
chloride in the entire membrane. 
2.3.3 Fractionation of Heparin 
Heparin was fractionated and gel electrophoresis was used to assess the success of 
the fractionation.  Lanes of fractionated heparin were compared to lanes of enoxaparin 
and the original unfractionated heparin, which were used as the standards.  It was 
hypothesized that the fractionated heparin should look similar to the unfractionated 
heparin on the gel based on the molecular weight distribution found in the literature12 and 
the enoxaparin should represent a molecular weight distribution not contained in either 
the fractionated or unfractionated heparin samples.  Gel electrophoresis (see Figure 2.3) 
demonstrated that the fractionated heparin preparation did not extend quite as far down in 
MW as the unfractionated sample but was more similar to the unfractionated heparin 
because it is known that the molecular weight distribution of unfractionated heparin does 
not extend much below 7 kDa and that which does is a very small percentage.12  In 
contrast, the band for enoxaparin extended to a MW range far below that seen for the 
€ 
Rm (t) − Rmin
Rmax − Rmin
=1− 8(2n +1)2π 2n=0
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other two samples (Figure 2.3).  These data suggest that heparin was successfully 
fractionated, and contained little or no low MW fragments.  
             
Figure 2.3. Results of gel electrophoresis of various heparin preparatons; (A) contains fractionated 
heparin, (B) contains unfractionated heparin, and (C) contains enoxaparin (low molecular weight 
heparin).  Heparins were introduced onto the gel at the left of the figure (left side negative(-), right 
side positive(+)).  Gel was run at 16 W for 1.5 h. 	  
2.3.4 Electrochemical Characterization and Determination of Diffusion Coefficients for 
Fractionated Heparin in Plasticized PVC Films Doped with TDMACl Using Classic 
Potentiometry and Impedance Spectroscopy 
In this study, the fractionated heparin was used to study the extraction and 
diffusion of higher MW heparin species through polymeric plasticized membranes doped 
with TDMACl.  The fractionated heparin sample prepared in this work was used to rule 
out diffusion of low molecular weight heparins present in the unfractionated sample (i.e., 
species < 8 kDa), unlike earlier studies that used unfractionated heparin.  The 
potentiometric study was carried out using diffusion (transport) cells (see Figure 2.1) 
containing two solutions (50 mM NaCl and 5 mg/mL fractionated heparin in 50 mM 
NaCl) separated by the ion-selective polymer membrane.  Membrane thicknesses of 
between 100 and 250 µm were used to study the diffusion of the fractionated heparin. 
Like earlier studies carried out during the development of the sensor, an initial drop in the 
potentiometric signal characteristic of heparin is observed and after several hours, the 
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reversal in the potentiometric signal is also observed (see Figure 2.4) for every thickness 
of the membranes.  However, the thinner membranes exhibit a much faster reversal in 
signal when compared to the thicker membranes, which is predicted by the theoretical 
model. Diffusion coefficients were calculated and an average value of ca. 2.7x10-9 cm2s-1 
± 0.27 (SD for n=15 measurements) was determined from all of the membranes tested.  
The clear reversal in EMF signal and relatively consistent diffusion coefficient values for 
the heparin-TDMA complex moving within the membrane, no matter what the thickness 
of the membrane, strongly supports the heparin extraction model and cannot be predicted 
to occur if only interfacial adsorption occurs.   
                      
Figure 2.4. Dynamic potentiometric response curves of ion-selective membranes containing TDMACl 
with thicknesses of 60.1 µm, 76.5 µm, 180.5 µm, and 193.5 µm, from left to right, respectively, after 
addition of 5 mg/mL of heparin to the frontside of the membrane. 
 
Enoxaparin (average MW = 4500 Da) was also studied using the diffusion cell 
setup.  The diffusion coefficient calculated for enoxaparin is expected to be larger than 
the fractionated heparin samples, and indeed, a diffusion coefficient of 3.2 x 10-9 ± 0.60 
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cm2s-1 (for n=9 measurements) is found base on the rate in EMF reversal.  Using a 95% 
confidence level, the diffusion coefficients calculated for heparin and enoxaparin are 
significantly different.  The same initial potential change and reversal in signal is 
observed as the fractionated heparin samples.  This may be further evidence that the 
fractionated heparin did not contain LMW heparin and that it is possible for larger 
molecular weight fragments of heparin to be extracted into the bulk of the organic 
membrane phase.   
The diffusion coefficients determined here were calculated using the given 
membrane thickness (for an experiment with that membrane) and the slope of the linear 
region (Figure 2.4) in the reversal in EMF signal, B, by Equation 5.  The experimental 
slopes for the thinner membranes are much steeper than the thicker membranes because 
heparin reached the backside of the membrane sooner, and hence the flux of heparin to 
the back-side is greater for the thinner membranes.  The calculated diffusion coefficients 
are very similar for all of the membrane thicknesses.   
Electrochemical impedance spectroscopy was also employed to examine whether 
heparin is extracted and diffuses through the membrane as an ion-pair with TDMA+.  
Impedance spectroscopy is a useful technique to determine the total bulk resistance of the 
membrane.  This total resistance depends on the concentrations of the mobile ionic 
species in the membrane. It can be seen in Figure 2.5b that the theoretical curve (solid 
line) calculated with the diffusion coefficient from the slope of the reversed 
potentiometric signal (Figure 2.5a), fits the measured impedance data quite well.  The 
bulk resistance was measured every 2 h over a ca. 80 h period using the same diffusion 
cell set-up as employed for the potentiometric experiments.  As heparin diffuses into the 
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membrane, the resistance of the membrane increases, due to the lower mobility of the 
heparin-TDMA+ ion pair compared to the chloride ion. 
                           
Figure 2.5. (A) Potentiometric response curve of a 300 µm ion-selective membrane.  (B) Bulk 
resistance of the ion-selective membrane, the dots are the experimental results, the solid line is the 
theoretical response curve based on Equation 7.  Note: The potentiometric curve in Figure 2.5A was 
generated from the same membrane used to map resistance as function of time in Figure 2.5B.  
Potentiometric curves in Figure 2.4 were generated from different membranes. 	  
2.4 Conclusions 
We have provided new experimental results and corresponding theory concerning 
the extraction and diffusion of high charge density polyanionic heparin into and through 
plasticized PVC membranes doped with TDMACl, the same membranes used to prepare 
potentiometric heparin sensors.  These results reaffirm earlier experiments3,4 regarding 
the mechanism of potentiometric polyanion response, with fractionated heparin 
possessing only higher MW components still exhibiting the reversal in EMF response 
expected as it reaches the backside of the membrane.  This reversal of potentiometric 
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signal after several hours cannot be explained by a surface adsorption only process. 
Theory predicts this reversal, since, as heparin arrives to the backside of the membrane, 
the backside phase boundary potential starts to approach the phase boundary potential of 
the front-side, resulting in a smaller membrane potential (eventually approaching zero).  
It is important to emphasize that the ∆EMF depends almost entirely on the ion 
concentrations at the backside and the front-side of the membrane.  Hence it is important 
that the extraction and diffusion of heparin is further verified independently via 
impedance spectroscopy, that provides information about the total concentration of 
heparin within the bulk of the membrane phase.  Clearly, the impedance data presented 
here also supports the presence of the high MW fractionated heparin species within the 
polymeric membrane phase. 
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CHAPTER 3 
DETECTION OF OVERSULFATED CHONDROITIN SULFATE 
CONTAMINANT/ADULTERANT IN COMMERCIALLY AVAILABLE HEPARINS:  
A PRACTICAL APPLICATION OF POTENTIOMETRIC POLYANION SENSITIVE 
POLYMERIC MEMBRANE ELECTRODES 
 
3.1 Introduction 
 Large doses of heparin are administered every day in hospitals both during 
surgery and therapeutically for conditions like deep vein thrombosis.1 In 2008, several 
lots of pharmaceutical grade heparin were recalled due to adverse side effects that 
included allergic type reactions and, in more severe cases, death.  It was later found that 
crude heparin from China, which Baxter Inc. (Deerfield, IL) had purchased and used in 
their heparin preparations, had been adulterated with a synthetic contaminant, 
oversulfated chondroitin sulfate (OSCS).  The presence of OSCS was directly linked to 
the adverse reactions associated with particular heparin lots.  
Over one million multi-dose vials of heparin are purchased every month, half of 
which are manufactured by Baxter Inc.2  Before the 2008 outbreak of adverse side 
effects, the only screening method required for commercially available heparin was the 
Factor Xa/IIa ratio test, which is used to determine heparin efficacy and purity.  The 
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Factor Xa/IIa ratio test, with respect to OSCS detection, was determined to have 
detection limits of 15 wt % OSCS in heparin, far above the toxicity levels of OSCS, 
which are ≥ 5 wt %.3  Since OSCS has strong anti-factor IIa activity and only one half of 
the activity of heparin toward anti-factor Xa, samples containing 5-25 wt% OSCS in 
heparin went undetected because measurements still fell within the United States 
Pharmacopeial standards (Xa activity)/IIa activity = 0.9-1.1).4  
A detailed investigation into the contaminated heparin episode was executed by 
the FDA.  They utilized capillary electrophoresis (CE) and determined which commercial 
lots were suspected to have the contaminant/adulterant, and with further isolation, proton 
nuclear magnetic resonance (H-NMR) was used to elucidate the structure of the 
contaminant/adulterant.  Later, CE and H-NMR became required screening methods 
within the Heparin Sodium USP Monograph.3  Although these screening methods are 
reliable and were effective in discovering the OSCS species present in the samples that 
caused patient deaths, they can be time consuming, expensive, require extensive training 
and knowledge to use the instruments, and are not easily applicable in clinical settings.   
Potentiometric plasticized polymeric membrane-based polyion sensors for the 
determination of heparin were pioneered by the Meyerhoff group in the early 1990’s.5-8  
These sensors have many applications, including monitoring heparin in whole blood,6 
monitoring enzymatic reactions,9 and measuring carrageenan in food products.10  The 
sensor mechanism is based on a non-classical non-equilibrium response and is described 
in Chapter 2.  It is easy to differentiate between glycosaminoglycans (GAGs) when 
measuring them with this polyion sensor.  Generally, since the charge density of these 
GAGs largely contributes to the EMF response that is observed during measurements, the 
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variations of charge density amongst GAGs can be easily observed.  Specific GAGs 
(Figure 3.1), measured by this sensor in 120 mM NaCl in 10 mM phosphate buffer, have 
characteristic EMF changes associated with them.  When a concentration of target 
analyte is measured that is large enough to induce the equilibrium response of the sensor, 
a large EMF drop in sensor signal is observed, and the overall potential change is 
associated directly to the charge density of the polyion analyte present; the larger the 
charge density of the polyion, the larger the potential change that is observed (see Figure 
1.2 chapter 1).6,11  For example, when measuring heparin, which has a charge density of ~ 
-4 per discharide unit, in 120 mM NaCl/10 mM PBS, an approximately -50 mV change in 
EMF of the measurement cell occurs.  In contrast, chondroitin sulfate, which has a much 
smaller charge density, -2 per disaccharide unit, only yields  ~-35 mV change in signal. 
                 
Figure 3.1. Different glycosaminoglycans and their respective potential changes in a background 
solution of 120 mM NaCl/10 mM phosphate buffered saline. 
 
   When two different GAGs are present in the same sample, the potential change 
that is observed is governed by the higher charge density species because the 
thermodynamics of the cooperative ion-pair formed between TDMA+ and polyanion are 
in favor of the larger charge density species.11  This phenomenon allows for the detection 
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of OSCS in commercially available heparins simply because the charge density of OSCS 
is much larger than heparin itself.   
In 2008, Wang, et al. reported that the heparin sensor could be used to determine 
levels of OSCS down to 0.5 wt% within heparin preparations.11  In that work, a slow drift 
of the potential, which eventually stabilized at approximately -80 mV (the overall 
potential change associated with OSCS), was observed when the OSCS levels were < 5 
wt% of the heparin sample.  Levels of OSCS above this 5 wt% threshold immediately 
induced a rapid equilibrium phase boundary potential change at the outer 
membrane/sample interface of the sensor resulting in an ca. -80 mV change in cell 
potential.   
Although this sensor had been successful in determining OSCS in adulterated 
heparin samples prepared in the research laboratory, it had not been used to measure the 
OSCS in any commercial samples known to be contaminated with this agent.  Herein, the 
ability to detect the presence of OSCS in commercial lots of Baxter heparin is 
demonstrated and shown to correlate perfectly with the NMR data provided by Baxter for 
these lots.   
3.2 Experimental Section 
3.2.1 Polyion Sensor Preparation 
 The membrane cocktail was made using 66 wt% poly(vinyl chloride) (PVC) (high 
molecular weight, Fluka), 32.5 wt% dioctyl sebecate (DOS) (Fluka), and 1.5 wt% 
TDMACl (26.2 mM) (Fluka). This mixture was dissolved in distilled tetrahydrofuran 
(THF) (Fisher) to yield a 100 mg/mL mixture at a volume of 15 mL.  To assemble the 
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polyion-selective disposable sensors, Tygon tubing (i.d. 1/16 in., o.d. 1/8 in., ¾ in length) 
was placed onto the distal tip of a closed-end glass capillary tube (o.d. 0.8-1.1 mm) with 
the closed end of the capillary protruding out from the tubing ~ 4 mm.  This end was then 
dip-coated with the membrane cocktail 12 times, allowing 10 min in between each dip-
coat for the THF to evaporate.  Once the tubing/capillaries were completely dip-coated, 
they were left to dry over night.  Before measurements, tubing/capillaries were 
conditioned in 120 mM NaCl in 10 mM PBS, pH 7.4, for approximately 15 min before 
the glass capillaries were carefully removed from the Tygon tubing, leaving a sensing 
membrane at the distal end.   The Tygon tubing was then filled with the same buffer and 
placed back into the conditioning solution over night.  Conditioned sensors were fitted 
onto the narrow end of 1 mL disposable pipette tips with a thin Ag/AgCl wire (0.5 mm) 
inserted inside the pipette tip and into the inner buffer solution.  Parafilm was used to seal 
the wider end of the pipette tip with the Ag/AgCl wire extending out from the top and 
parafilm (Figure 3.2).            
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Figure 3.2. Polyion sensor arrangement where the conditioned polyion selective sensor, made from 
dip-coating PVC tubing with membrane cocktail, is inserted onto the end of a 1 mL Eppendorf 
pipette tip. 	  
3.2.2 Measurements in Commercial Lots of Heparin 
 Multi-dose injection vials of heparin concentrations in 1000, 5000, and 10,000 
USP units/mL were supplied by Baxter Healthcare Corporation, Inc. (Deerfield, Ill.).  All 
samples were diluted to 1 mg/mL (182 units/mL) concentrations with a total volume of 4 
mL for sensor measurements.   Sensors were immersed into sample solutions with 
continuous stirring and measured against a commercial miniaturized Ag/AgCl reference 
electrode (BASi, West Lafayette, IN) filled with 3 M KCL.  Three membrane electrode 
sensors were used per sample to obtain a mean and standard deviation for each sample.   
All sensors were connected to a Lawson Labs 8 channel high impedance interface 
(Pennsylvania, USA) during the ~20 min data acquisition period.  See Figure 3.3 for the 
experimental set-up. 
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Figure 3.3. Experimental set-up.  All measurements were made using three heparin sensors to obtain 
a mean voltage change ± standard deviations for all samples tested.  The larger circle contains an 
enlarged view of the experimental cell.  Heparin sensors were approximately 1.5 cm in length 
extending from the narrow end of a 1 mL Eppendorf pipette tip.  	  
Three to six sensors from each batch of polyion sensors were used to measure a 
standard heparin solution of 1 mg/mL concentrations under constant stirring to ensure the 
overall potential change of a known uncontaminated heparin sample measured with 
sensors from a given batch was ~ -50 mV.  Overall potential changes were determined by 
subtracting the stable starting baseline EMF value recorded in 120 mM NaCl/10 mM 
PBS, pH 7.4, from potentials generated 10 min after the injection of the heparin samples.   
3.3 Results and Discussion 
Twelve commercial heparin samples were analyzed for the presence of OSCS 
using the homemade potentiometric polyion sensitive membrane electrodes.  When 
concentrations of OSCS in heparin preparations do not exceed 5 wt% (as determined by 
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Baxter using H-NMR), the equilibrium response to OSCS is not immediately induced; 
rather the equilibrium EMF response to heparin, or responses somewhat larger than 
heparin but not equal to -80 mV (as concentrations of OSCS increases from 0.5-< 5 wt%) 
are initially observed, and then a drift more negative to the equilibrium EMF response of 
OSCS, as reported in Wang, et. al.11  A different trend is observed when contaminated 
samples have concentrations of OSCS that are high enough to induce the equilibrium 
response toward OSCS (≥ 5 wt% in heparin), as previously mentioned, where sensors 
exhibit immediate potential changes of ~ -80 mV.  The concentrations of OSCS in the 
heparin samples provided by Baxter were high enough to impose the rapid equilibrium 
phase boundary potential change at the membrane/sample interface associated with their 
charge densities.  Therefore, it appeared that none of the contaminated samples that were 
screened with the potentiometric polyion sensors contained concentrations of OSCS less 
than the 5 wt% threshold, suggesting that all samples were contaminated/adulterated with 
amounts that exceeded the toxicity level of OSCS.   
Samples were monitored for ~10 min after injection and determined to contain 
OSCS or not contain this species based on the total change in EMF from baseline values.  
Samples were considered void of OSCS if the sensors used to make the measurement 
exhibited equilibrium EMF shifts of approximately -50 mV in respect to background 
potentials.  Potential changes that reached ~ -80 mV with respect to the initial 
background potential indicated that the sample was contaminated with OSCS (see Figure 
3.4 for EMF data obtained for four representative lots of Baxter heparin).  NMR data was 
provided by Baxter and used to correlate the potentiometric data with known amounts of 
OSCS present.   Exactly 100% of the 12 lots of heparin screened via the heparin sensor 
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were determined to be in agreement with the NMR data for each sample regarded as 
contaminated or uncontaminated (see Table 3.1).   
 
 
 
Figure 3.4. EMF changes of two contaminated samples (A and B) and two clean samples (C and D) 
with amounts of OSCS determined by NMR data provided by Baxter Inc.  Each sample was 
measured with three sensors to obtain standard deviations.  Average potential and standard 
deviations are as follows: (A) Avg = -78.3 mV, s.d. = 2.11 mV; (B) Avg. = 79.9 mV, s.d.= 2.32 mV, (C) 
Avg. = -52.8 mV, s.d. = 1.59 mV; (D) Avg.  = -55.3 mV, s.d  = 1.24 mV. 
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Table 3.1.  Potentiometric responses and standard deviations for sensors used to measure Baxter 
heparin samples.a   
 
  a Values reported in the “% OSCS in Sample” column represent wt% of OSCS determined by 
NMR in each lot.   All values reported in red are considered to be contaminated/adulterated samples.  
ND is short for ‘none detected’.   All NMR data were provided by Baxter. 	  
3.4 Conclusions 
The data provided in this chapter suggests that simple potentiometric polyanion 
sensors can accurately screen commercially available heparin for the presence of high 
charge density species like OSCS.  It should be noted that this method is not meant to 
replace CE or H-NMR.  However, it could compliment the screening process by pre-
inspecting samples to determine if further screening is necessary, lowering the total cost 
of screening and concomitantly lowering the cost of heparin products.  Furthermore, this 
method could readily be used in clinical or other commercial settings (including facilities 
where heparin is extracted from pig tissue, etc.) that don’t have access to high cost H-
NMR and CE instruments. 
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 Overall, in this work, potentiometric polyanion sensors have been proven to 
provide a simple method for screening commercially available heparin preparations that 
is accurate, robust, easy to use, and also inexpensive. 
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CHAPTER 4 
POLYION SELECTIVE POLYMERIC MEMBRANE BASED PULSTRODE AS A 
DETECTOR IN FLOW-INJECTION ANALYSIS 
4.1 Introduction 
Polyanions such as glycosaminoglycans (GAGs) (e.g., the anticoagulant heparin 
and the anti-inflammatory agent chondroitin sulfate), sulfated polysaccharides (e.g., 
fucoidan, pentosan polysulfate, carageenans), and polyphosphates, as well as many 
important polycationic species (e.g., arginine-rich polypeptides including protamine (the 
antidote of heparin), polymers of quaternary ammonium species, etc.) are difficult 
analytical targets for direct detection owing to their lack of strong absorbance at 
wavelengths > 260 nm and no presence of electrochemically active domains.  To address 
this problem, non-equilibrium polyion selective polymeric membrane electrodes for 
heparin and protamine (as representative biomedically important polyions) were first 
introduced by our group in the early 90’s.1-6 Such devices have been demonstrated to 
have many potential practical applications including the measurement of heparin in 
whole blood,2 the quantitation of carrageen in food products,7 and the detection of 
enzyme activities that cleave polyions into smaller fragments not sensed by the electrodes 
and the detection of high-charge density contaminants in commercially available 
heparins.8,9  These sensors are prepared by doping polymeric membranes (e.g., 
plasticized PVC) with lipophilic anion-exchangers (tridodecylmethylammonium chloride 
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(TDMACl)) for polyanions or lipophilic cation exchangers (e.g., dinonylnaphthalene 
sulfonic acid (DNNSH)) for polycations that can form strong cooperative ion pairs with 
the target polyion, causing polyion extraction into the organic membrane phase and hence 
a change in the phase boundary potential of the membrane.3  Although such sensors are 
inexpensive and robust, they are irreversible, and hence they are usually employed as 
single-use devices and are not adaptable to higher throughput flow-through analysis 
methods (e.g., flow-injection analysis (FIA)), where fully reversible potentiometric 
responses is required.   
The Bakker group first pioneered a reversible polyion-selective sensor in the early 
2000s and termed the device a pulstrode.10,11  Since then, these pulstrodes have been used 
to detect both polyanions and polycations.11,12  The pulstrode is a three-electrode system 
involving working, counter, and reference electrodes, where the polymeric membrane 
within the working electrode is doped with a lipophilic ion-exchanger salt with no 
intrinsic ion-exchange properties.  Although the membrane does not have ion-exchange 
properties initially, a galvanostatic pulse between the working and counter electrode for a 
short time period (1 s) can polarize the lipophilic salt species in the membrane phase and 
induce localized ion-exchange at the membrane/sample interface.  This provides the basis 
for subsequent potentiometric measurement during a period when no current pulse is 
applied.  A typical measurement consists of a three-pulse sequence: the galvanostatic 
pulse, an open-circuit period, and then a potentiostatic pulse at a given applied potential.   
The principles of this method and the function of each of these steps have been provided 
in prior work reported by Bakker and coworkers10,11 with respect to polycation sensing, 
as well as Gemene et al.12 for polyanion sensing.  
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In principle, the pulstrode sensor, unlike the earlier single-use polyion selective 
membrane electrodes, should be useful as a detector in flow-through analytical systems.  
Herein, we explore for the first time this avenue by demonstrating the utility of a 
plasticized PVC membrane-based electrode containing the lipophilic salt of 
(TDMA/DNNS) as both a polycation and polyanion sensitive detector in a simple flow-
injection analysis (FIA) arrangement.   Both protamine and heparin are used as model 
analytes, and it is shown that the pulse sequence for detection can be optimized to 
achieve sample throughputs of up to 20 samples/h with detection limits of 10 µg/mL 
protamine and 40 µg/mL heparin, respectively, when a 200 µL injection loop is 
employed. 
4.2 Experimental Section 
4.2.1 Reagents 
High molecular weight poly(vinyl chloride) (PVC), 2-nitrophenyloctyl ether (o-
NPOE), tridodecylmethylammonium chloride (TDMACl), tetrahydrofuran (THF), 
heparin sodium salt, protamine sulfate salt from salmon, and all buffer salts were 
purchased from Sigma Aldrich (St. Louis, MO).  Dinonylnaphthalene sulfonic acid 
(DNNSH) as a 49% solution in xylenes was a gift from King Industries (Norwalk, CT). 
4.2.2 Preparation of Ion-exchanger Salt 
 The lipophilic ion-exchanger salt was prepared by metathesis in benzene in a 1:1 
molar ratio of DNNSH and TDMACl.  The benzene-salt solution was washed several 
times with deionized water until the aqueous solution was neutral.  The benzene phase 
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was then dried, and the residual salt was re-dissolved in THF and then dried again for use 
in preparation of the polyion selective membranes. 
4.2.3 Membrane Preparation 
 All polyion selective membrane films contained 10 wt% of TDMA/DNNS salt 
and were ~200 µm thick.  The sensing membranes were all formulated to contain a 1:2 by 
weight ratio of PVC and o-NPOE plasticizer.  All membrane components were dissolved 
in THF and the membrane was prepared by solvent casting this solution into glass rings 
on glass plates and letting the solutions dry overnight (in fume hood).  
4.2.4 Electrodes 
 Membranes were cut with a cork borer (8 mm diam.) from the parent membrane 
and placed into an electrode body (Oesch Sensor Technology, Sargans, Switzerland).  
The actual membrane area was 20 mm2.  All sensors were conditioned overnight in 10 
mM phosphate buffer, pH 7.4, with 10 mM NaCl added, and the inner-filling solution in 
contact with the inner Ag/AgCl reference was the same as the outer conditioning 
solution.  The external reference electrode was a double-junction Ag/AgCl electrode with 
3 M KCl as the inner filling solution and 1 M LiOAc as a bridge electrolyte.  A coiled Pt-
wire was used as a counter electrode for all pulsed chronopotentiometric measurements 
(see Figure 4.1). 
4.2.5 Measurements 
 A conventional three-electrode set-up was used for the pulstrode measurements 
with the TDMA/DNNS-based polymeric membrane electrode serving as the working 
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electrode with the flowing sample passing over the outer surface of the membrane in a 
wall-jet configuration (see Figure 4.1).  The solution outlet holes of the plastic syringe 
that provided the housing for the wall-jet assembly entered into a small beaker into which 
the reference and counter electrodes were placed.   
 
Figure 4.1. Schematic diagram of the flow-injection system coupled with polyion selective polymeric 
membrane-based pulstrode used for the experiments reported. 	  
The electrochemical measurements were conducted with an AFCBI bipotentiostat 
(Pine Instruments, Grove City, PA) controlled by a NI-DAQPad 6015 interface board and 
LabVIEW 8.6 data acquisition software (National Instruments, Austin, TX) on a PC 
computer.  Initially, an uptake (galvanostatic pulse) time of 1 s (magnitude and direction 
changed depending on the target analyte), a zero-current pulse of 0.5 s, and a 
potentiostatic pulse of 0 V vs. Ag/AgCl (stripping potential) of 15 s were used.  
Eventually, to enhance throughput, the potentiostatic pulse period was varied to examine 
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the shortest period that still provide a full return to baseline potential.  For measurements 
involving heparin, a 20 µA current was employed during the galvanostatic pulse, and for 
protamine a -12 µA current pulse was applied.  These current magnitudes have been 
previously optimized for largest EMF responses during the zero current pulse period 
under static conditions (in absence of flow) for heparin12 and protamine.11 The potentials 
were sampled as the averaged data during the last 10% time period of the 0.5 s zero 
current pulse.  To assess the composition changes in the membranes of the working 
electrode as a function of use time in the FIA system, classical potentiometric 
measurements were conducted with the working electrodes using a 16-channel, high-
impedance interface (Lawson Laboratories Inc., Malvern, PA) vs. the same double 
junction reference electrode used in the pulsed chronopotentiometric FIA measurements.  
All experiments were carried out at room temperature (21-23 ˚C). 
4.2.6 FIA System 
 A schematic representation of the flow injection analysis system used throughout 
the experiments reported here is shown in Figure 4.1.  A peristaltic pump (MINIPULS3, 
Gilson, Middleton, WI) was used to induce carrier stream (buffer) flow and a 6-port 
manual injection valve (VICI, Houston, TX), equipped with a 750 µL sample loop (or 
200 µL sample loop for higher throughput rate only), was employed to introduce samples 
into the system.  A polyion selective membrane electrode, serving as detector, was 
mounted in a wall-jet mode using custom made adapter (plastic syringe housing).  The 
entire flow-through system was assembled using Teflon tubing (0.8 mm i.d.). 
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4.3 Results and Discussion 
 In this work, a polyion selective pulstrode is employed as a universal polyion 
detector in an FIA system to detect both polycations and polyanions with the same 
membrane composition.  Initial preliminary experiments were conducted using a carrier 
stream of 10 mM phosphate buffer, pH 7.4, with 10 mM NaCl at a flow rate of 0.6 
mL/min and a 750 µL sample loop.  The large sample volume employed was to ensure 
that an adequate number of data points (EMF measurements) could be obtained in the 
presence of the sample to define a full sample peak, given that a voltage signal is only 
recorded every 16.5 s. (see parameters for pulses in Experimental Section).  The polymer 
membrane of the working electrode is doped with a 1:1 molar ratio of 
tridodecylmethylammonium (TDMA+) and dinonylnaphthalene sulfonate (DNNS-), 
where TDMA+ provides selectivity to polyanions (heparin)12 and DNNS- to polycations 
(protamine)11 when the membrane is polarized.  During a typical pulse sequence, the 
galvanostatic pulse is applied through the working sensor and counter electrode, during 
which the membrane is polarized, with a concomitant ion-flux of complementarily 
charged ions migrating from the sample towards the polymeric membrane (see Figure 
4.2).  Under an anodic current pulse, the lipophilic ion-exchanger salt ions are 
redistributed in the membrane, with TDMA+ migrating toward the sample/membrane 
interface, and DNNS- moving toward the inner interface in contact with the fixed internal 
electrolyte solution.  Thus, the outer interface becomes an anion exchange interface and 
the inner solution/membrane a cation exchange interface (see Figure 4.2).  An analogous 
process occurs when an initial cathodic current pulse is applied, with DNNS- moving 
toward the sample/membrane interface for selective detection of polycations.  During the 
subsequent open circuit portion of the sequence, the previously extracted background 
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ions are exchanged with the target polyions from the sample to provide a phase boundary 
potential change that relates to the concentration of polyions present.  The measured EMF 
during this period is void of undesired iR drop, making it analogous to classical zero 
current potentiometric measurements.  During the potentiostatic pulse, the membrane is 
depolarized, and all ions that are initially extracted are stripped out to restore the 
membrane to its original composition, making the sensor fully reversible and suitable for 
FIA measurements. 
	  
Figure 4.2. Movement of salt and ions within membrane and at interfaces during pulse sequence 
employed for detection of polyanions using anodic current pulse in FIA arrangement.  The polyion is 
represented by Pz-, the interfering ions by I+ and A-, and R+ and R- are the TMDA+ and DNNS- ions 
of the lipophilic ion-exchanger salt within the membrane phase.  It should be noted that smaller 
anions (A-) also enter outer surface of sensing membrane during pulse 1 period, but are eventually 
outcompeted for serving as the counteranions to R+  sites by the polyanions (Pz-). 	  
 The typical dynamic potentiometric responses of the pulstrode detector in the FIA 
mode (using preliminary pulse parameters) toward injected samples of protamine and 
heparin samples are shown in Figure 4.3.  All signals, obtained for differing 
concentrations of both protamine and heparin, exhibit good reproducibility for duplicate 
injections and reversibility.  However, it should be noted that these measurements are 
only used to demonstrate the detectable concentration range and not employed to 
	   62	  
demonstrate true precision and stability of the sensors (see Figures 4.5 and 4.6, below, for 
precision data).  In the polyanion sensing mode that employs an anodic current pulse (i.e., 
heparin as the target analyte), a slight negative baseline shift is observed, which may be 
due to very small amounts of higher MW heparin remaining inside the membrane during 
the potentiostatic pulse due to the very strong cooperative ion pair it makes with 
TDMA+.4   However, the overall potential changes from baseline for a given 
concentration of heparin remained relatively constant and reproducible.  The linear 
response range for protamine injections is 10 - 100 µg/mL, whereas for heparin the range 
is from 40 to 200 µg/mL (equivalent to 7 -36 Units/mL).  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure 4.3. Dynamic potentiometric response of polyion pulstrode to (A) protamine; duplicate 
sequential injections of standards in range from 10 µg/mL - 100 µg/mL; and (B) heparin; duplicate 
sequential injections of standards in range from 40 µg/mL - 200 µg/mL in 10 mM phosphate buffer, 
pH 7.4, with 10 mM NaCl present.  The diluent stream was the same buffer solution and flow rates 
were set at 0.6 mL/min.  Numbers above and below peaks represent concentrations in µg/mL.  Every 
100 pulses is ~30 min. 
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Since the measurements are conducted under flowing conditions, it is essential to 
determine the stability of the sensors.  Two different pulstrode sensors with the same 
membrane composition were used for calibrations toward protamine and heparin, 
respectively.  Each sensor was calibrated twice a day and placed in stagnant conditioning 
buffer solution between measurements.  The FIA response toward protamine was found 
to be stable for 3 d, while responses towards heparin were stable over a 5 d period, with 
stability defined as potential change values of less than 5% in peak heights when 
compared to those on day 1 of operation for a particular sensor.  After these times, the 
overall EMF responses decreased significantly.  The reason for the longer stability 
towards heparin may be related to the lipophilicities of each portion of the ion-exchanger 
salt within the membrane phase.  Values of organic-aqueous phase partition coefficients 
for DNNS- and TDMA+ were determined using Virtual Computational Chemistry 
Laboratory.14  The results show that DNNS- has a ca. two orders of magnitude smaller 
partition coefficient compared to that of TDMA+ (log Kpart  = 7.71 vs. 9.75).   
To confirm that DNNS- was more quickly washed out from the membrane phase, 
studies were conducted using classical potentiometry using KBr as the analyte species.  
For freshly prepared membranes, the ion-exchanger salt in the membrane has no intrinsic 
ion-exchange properties and, therefore, does not respond to any ions present in the 
sample solution in classical zero-current potentiometry (see Figure 4.4A).  However, 
when sensors are placed in a continuous flow arrangement (exposed to flowing 10 mM 
phosphate buffer, pH 7.4. with 10 mM NaCl) without pulsing for 3 days and then tested 
on the bench using conventional potentiometry, they exhibit a more significant negative 
voltage response towards additions of standard 1 mM KBr compared to freshly made 
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working electrodes that were not exposed to flowing conditions for 3 d (see Figure 4.4C).  
This anionic response to bromide ion suggests that some excess TDMA+ was present in 
the polymeric membrane phase following the extended exposure to flowing buffer.   
          
Figure 4.4. Open circuit potentiometric response of polymeric membrane electrode to 10-3 M KBr (A) 
before pulstrode measurements; (B) after 500 pulse sequences in flow mode, anodic current applied 
during galvanostatic pulse; (C) after 3 d in flow system with no galvanostatic pulsing, and (D) after 
500 pulse sequences in flow mode with cathodic current applied during galvanostatic pulse.  All 
measurements were conducted in 10 mM phosphate buffer, pH 7.4, containing 10 mM NaCl. 
 
When a fresh sensor is placed under flowing conditions with the polyanion pulse 
sequence but only for 500 pulses (during 1st day), only a very small negative potential 
change is observed in the presence of KBr, similar to the sensor that has not been 
exposed to flowing conditions.   However, when the sensor is polarized in the flow mode 
for 3 d using a cathodic current pulse (as would be employed for polycation detection) it 
exhibits a much larger negative potential change of ~ -30 mV in response to 1 mM KBr 
in the static potentiometric beaker experiment (see Figure 4.4D).  This is likely because 
as the cathodic current is applied during the galvanostatic pulse, DNNS- moves towards 
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the sample/membrane interface and concentrates in this region, allowing it to be more 
efficiently washed out from the membrane phase owing to its decreased lipophilicity.  In 
contrast, when the anodic current pulse is applied for polyanion sensing, the DNNS- 
moves towards the membrane/inner filling solution interface, where the solution is 
stagnant and DNNS- can partition back into the membrane, while TDMA+ ions move to 
the front side of the membrane.  Since TDMA+ is more lipophilic than DNNS-, much less 
DNNS- is washed out from the membrane by the flowing conditions and hence the 1:1 
molar ratio of DNNS- to TDMA+ within the sensing membrane remains constant for a 
longer period of time when using the polyanion sensing mode of operation.  As expected, 
this ‘extraction’ effect is much less pronounced in static measurements with polyion 
sensors, and likely also with pulstrodes used in similar non-flowing conditions. 
The most widely used polyions in pharmaceutical applications are heparin and 
protamine.15-20 Protamine is an arginine rich polypeptide used as an antidote to the 
anticoagulant heparin in medical procedures where it binds strongly to heparin forming a 
neutral complex.17  Since large heparin doses can lead to bleeding complications, and 
protamine overdose is known to cause complement activation and other toxic effects in 
patients, monitoring of their concentration in blood is potentially quite useful.16-20  
Considering that the pulstrode response is also governed by the presence of sodium or 
chloride ions, experiments were carried out to determine both heparin and protamine in a 
FIA mode in which a physiological level of NaCl background is present. Experiments 
using samples made in a 10 mM phosphate buffer, pH 7.4, with 100 mM NaCl and using 
this same buffer as the carrier stream were therefore performed.  Significant 
potentiometric response to protamine is still observed (Figure 4.5A) when sensing 
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polycations, while indiscernible FIA signals for different heparin concentrations are 
observed in the polyanion sensing mode (data not shown).  This is consistent with the low 
responses toward heparin obtained in static (no flow) measurements using the pulstrode 
method under similar high NaCl conditions,12 and may relate to much slower kinetics of 
ion-exchange at the membrane/sample interface for heparin compared to protamine, 
given that the average MW of heparin is in the range of 15,000 daltons (compared to 
protamine MW = 5,100).21  Since the period where heparin can be effectively extracted 
into the membrane is only during the galvanostatic and open circuit periods (1.5 s), it is 
likely that significantly more protamine can be extracted during this short period than 
heparin, and thus the ability to outcompete the smaller counterions in the sample and 
membrane phases during and after the polarization period (Na+ in polycation sensing 
mode and Cl- in the polyanion sensing mode) is greater in the case of protamine sensing.
 To detect heparin under physiological conditions in the FIA mode, a constant 
concentration of protamine (60 µg/mL) was then mixed with standard amounts of heparin 
and the resulting mixture was injected into the FIA system operated in the polycation-
sensing mode.   As shown in Figure 4.5B, as the concentration of heparin increases, a 
decrease in the EMF response to protamine is observed.  The linear range of heparin 
concentrations that can be detected is from 10 - 35 µg/mL, which corresponds to 2 - 6 
U/mL, lying within the range of heparin concentrations used in certain clinical 
procedures, like open-heart surgery, extracorporeal membrane oxygenation, etc.16-19     
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Figure 4.5. (A) Calibration of DEMF response (peak voltage – baseline voltage) to protamine in flow-
injection mode in 10 mM phosphate buffer, pH 7.4, containing 100 mM NaCl.  It should be noted 
that standard deviation for n=3 injections at each concentration is so small that it cannot be observed 
for some data points; (B) Response to increasing concentrations of heparin with a constant 
concentration of 60 µg/mL protamine present in test sample in 10 mM phosphate buffer, pH 7.4, 
containing 100 mM NaCl.  Data in (B) represents testing with three different sensors with the same 
membrane composition in the FIA system, where standard deviation was calculated using data from 
all three sensors.  Flow rates for both A and B were set at 0.6 mL/min. 
 
It should also be noted that preliminary experiments using protamine spiked into 
blood plasma were also attempted with the new FIA arrangement.  Such experiments 
showed much larger positive EMF responses than for the same concentration of 
protamine alone in buffer.  This data is at odds with what was previously reported by 
Bakker and co-workers,11 using pulstrode type protamine sensors in the static mode, 
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where the presence of blood components did not perturb the ability to detect protamine.   
The only difference in the sensor employed in that earlier work vs. the present device was 
the anion exchanger species of the lipophilic salt used within the membrane, which was a 
tetradodecylammonium species, compared to tridodecylmethylammonium employed in 
this work.  However, the cationic species is moved toward the inner interface during the 
cathodic current pulse for polycation detection, and hence more research is needed to 
understand why some components in the blood that was tested in this work led to such a 
larger positive interference in detection of protamine. 
Flow-injection analysis normally allows for high sample throughput, and 
therefore flow rate and potentiostatic pulse duration times were further optimized to 
increase the number of samples analyzed per hour via the arrangement shown in Figure 
4.1.  To achieve higher throughput, we examined shortening the potentiostatic pulse 
segment of the sequence.   Experiments were carried out to determine how short the 
potentiostatic pulse could be without compromising reproducibility and maintaining a 
stable baseline.  In prior studies with pulstrodes, it was recommended to apply a 10-30 
times longer potentiostatic pulse than galvanostatic one to restore the membrane to its 
initial state.11   However, in the optimized polyion sensing FIA system it was found that 
decreasing the pulse to 6 s and thereby collecting data points every 8 s could be 
implemented without decreasing reproducibility.  In order to further improve the number 
of samples measured per hour, experiments were carried out to optimize sample loop size 
and flow rate.  Ultimately, a much smaller sample loop volume of 200 µL (vs. 750 µL 
originally) and increased flow rate up to 0.93 mL/min were employed.  Under these 
conditions, a sampling rate of 20 samples/h can be achieved with a relative standard 
	   69	  
deviation of ± 4.2% for the DEMF peak values when monitoring 60 µg/mL protamine 
(see Figure 4.6). 
 
Figure 4.6. Dynamic potentiometric response to repeated injections (n=20) of 60-µg/mL protamine in 
10 mM phosphate buffer, pH 7.4 containing 100 mM NaCl.  A sampling rate of approximately 20 
samples per hour has been achieved.  For data shown, the average DEMF = 33.7 mV  ± 1.42 mV 
(n=20).  Flow rate was set at 0.93 mL/min. 	  
Typically, 30-300 samples per hour can be handled in modern FIA systems, and 
even up to 1000 have been reported in specially designed microsystems with optical 
detection.13 Thus, the obtained sample throughput in this work may not appear to be 
significant.   However, given the high molecular weights of the species detected and 
considering that use of the traditional pulstrode method in a static mode requires 
manually changing sample and background solutions as well as further manually rinsing 
of all the electrodes between samples, detecting polyions at low levels with a throughput 
of 20 samples per hour is still a step forward.  By using more highly plasticized 
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membranes in the working electrode, or even fully organic liquid membranes, it may be 
possible to increase the rate of polyion extraction during and after the galvanic pulse.  
This might also lead to faster membrane recovery times during the potentiostatic pulse. 
Taken together, this approach might enable use of smaller sample volumes and shorter 
pulse sequences that may lead to even higher throughputs.   
4.4 Conclusions 
We have demonstrated, for the first time, that polyion selective pulstrodes can be 
used as detectors in an FIA measurement configuration.  Within such a flow-through 
system, this sensing mode provides relatively stable and reproducible signals that are 
proportional to both polycation and polyanion concentrations using a single working 
membrane electrode.  While demonstrated here for use in detecting heparin and 
protamine as model analytes, it is envisioned that this method could prove useful for 
quality control monitoring of a wide range of products/supplements that utilize polyions 
as active ingredients.  Further, the methodology described here should also be applicable 
in developing flow-through methods to detect specific enzyme activities that cleave 
polyions into smaller fragments that are not sensed by the pulstrode.  Finally, the use of 
polyion selective pulstrodes as universal detectors in preparative LC separation methods 
employed to isolate or fractionate polyion species, as well as their use as detectors in 
modern microfluidic devices, should also be possible.  
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CHAPTER 5 
MONITORING ENZYMATIC REACTIONS USING POLYMERIC MEMBRANE-
BASED POLYION SELECTIVE PULSTRODES  
 
5.1 Introduction 
The ability to study enzymatic reactions facilitates the understanding of biological 
processes.  Therefore, there are many techniques that have been developed to investigate 
substrate specificity, reaction rates, and other important biological characteristics of 
enzyme systems.  Commonly used methods for monitoring enzymatic activity include: 
spectrophotometry (UV-Vis), fluorometry, and chemiluminescence.  Although effective, 
these methods require significant sample preparations, can have selectivity issues, and 
cannot measure in turbid solutions (e.g., whole blood).1-3 
Ion-selective electrodes (ISEs) for polyanion detection were developed in the 
early 1990’s by the Meyerhoff group and have since been utilized for many applications 
including detection of the highly sulphated glycosaminoglycan heparin4-7 and monitoring 
enzymatic reactions (e.g., protamine/trypsin, and polyphosphates/acid phosphatase).8-10  
These sensors are easy to operate, are cost-effective, robust, and take measurements in 
complex and turbid media, such as whole blood.5  These sensors are unlike classical ISEs 
in the sense that their response is based on a non-equilibrium mechanism.7  For polyanion 
sensing, the membrane is doped with an anion-exchanging lipophilic quaternary 
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ammonium species that makes a strong cooperative ion pair with the target polyanion.  
This action yields a non-equilibrium steady-state phase boundary potential change 
(ΔEMF) at the membrane/sample interface.  When enzymatic activity is monitored with 
this sensor, the continuous change in substrate size (i.e., the digestion of the substrate) is 
evident in the degree of EMF response.  The smaller digested substrate fragments form 
much weaker cooperative ion-pairs with the ion-exchanger in the membrane, and 
therefore, the absolute value of the potential change decreases, which can be observed in 
real time.   
Although polyion sensors for both polyanions and polycations have been 
successfully used to monitor enzymatic activities,9,10 many of these studies have 
employed sensors that are considered single-use devices because the strong cooperative 
ion-pairs made between the ion-exchanger and target polyions are so strong that the 
dissociation of the ion-pair in the membrane phase is extremely slow.  Further, a small 
number of these ion-pairs can be extracted deep into the membrane8-10 before the enzyme 
can digest the target analyte.  Although a reversal in signal is observed during substrate 
digestion, the signal does not fully return to the baseline and therefore, the sensor cannot 
be re-used for a second measurement.  This single-use characteristic impacts other 
applications of this method and has recently been addressed by a fully-reversible 
chronopotentiometric method called pulstrode.11-14 The pulstrode configuration was 
pioneered by the Bakker group in the early 2000s, and within the last ten years has been 
developed for applications such as protamine detection in whole blood, protease activity 
monitoring,11-13 and reversible detection of heparin and other glycosaminoglycans.14  
Although protease activities have been successfully monitored by the pulstrode 
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technology,15 enzymatic reactions involving polyanions have not been previously 
reported in literature and are presented here for the first time.   Indeed, in this paper it is 
demonstrated that the cleavage of polyphosphate anions via acid phosphatase can be 
monitored in real time using a polyanion sensitive pulstrode.  Further, it is shown that 
inhibitors for such reactions can also be detected.      
5.2 Experimental Section 
5.2.1 Reagents 
High molecular weight poly(vinyl chloride) (PVC), 2-nitrophenyloctyl ether (o-
NPOE), tridodecylmethylammonium chloride (TDMACl), tetrahydrofuran (THF), 
hexametaphosphate, tripolyphosphate, acid phosphatase from potato, phosphatase 
inhibitor cocktail II, and all buffer salts were purchased from Sigma Aldrich (St. Louis, 
MO).    Dinonylnaphthalene sulfonic acid (DNNSH) as a 49 wt% solution in xylenes was 
donated by King Industries.  
5.2.2 Preparation of Ion-Exchanger Salt 
The lipophilic ion-exchanger salt was prepared by metathesis in benzene in a 1:1 
molar ratio of DNNSH:TDMACl.  The benzene-salt solution was washed several times 
with deionized water until the aqueous solution was neutral.  The solvent of the organic 
phase was evaporated and the resulting salt was re-dissolved in THF and kept as a 
solution to be used in the membrane preparation. 
5.2.3 Membrane Preparation 
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All membranes contained 10 wt% TDMA+-DNNS-ion-exchanger salt, 30 wt% 
PVC and 60 wt% o-NPOE.  All membrane components were dissolved in THF and 
prepared by solvent casting into glass rings (30 mm diameter), which were left to dry 
overnight.  A membrane cocktail containing 10 wt% inert lipophilic salt TDMA+-DNNS-, 
PVC and o-NPOE 1:2 by weight with approximate thickness of 200 µm was employed 
for all experiments. 
5.2.4 Electrodes 
Membranes were cut with a cork borer from the parent membrane and placed into 
a Philips electrode body (Oesch Sensor Technology, Sargans, Switzerland).  All sensors 
were conditioned overnight in 1 mM NaCl, and inner-filling solutions were the same as 
the conditioning solution, which were in contact with an internal Ag/AgCl reference 
electrode.  The external reference electrode was a double-junction Ag/AgCl electrode 
(Accumet 13-620-658, Fisher Scientific) with 3 M KCl as the inner filling solution and 1 
M LiOAc as a bridge electrolyte.  A coiled Pt-wire was used as a counter electrode for all 
pulsed chronopotentiometric measurements. 
5.2.5 Measurements 
A three-electrode set-up was used for pulstrode measurements that employed a 
TDMA+-DNNS--doped membrane working electrode, a commercial external double-
junction reference (Accumet 13-620-658, Fisher Scientific), and a platinum counter 
electrode, which were all immersed into the sample solution/buffer of 2-(N-
morpholino)ethanesulfonic acid at pH 5.2 (MES).  Phosphatase inhibitor was used as 0.5 
and 1 v% stock solutions in MES buffer, pH 5.2 of the original proprietary blend.  Both 
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the substrate and enzyme were dissolved in MES buffer, pH 5.2, immediately before use.  
Before measurements, varying concentrations of inhibitor and the substrate were mixed 
into the background solution.  After 3 pulse sequences, the enzyme was injected into the 
solution.  The final concentrations of the substrate and enzyme were 40 µg/mL and 0.75 
U/mL, respectively.  The measurements were conducted with an AFCBI biopotentiostat 
(Pine Instruments, Grove City, PA) controlled by a NI-DAQPad 6015 interface board and 
LabVIEW 8.6 data acquisition software (National Instruments, Austin, TX) on a PC 
computer. Measurements were based on a three-pulse sequence involving a 1 s, 20 µA 
galvanostatic (uptake) pulse, a 0.5 s open circuit measurement period, and a 15 s, 0 V 
potentiostatic (stripping) pulse.  The potentials were sampled as the averaged EMF values 
of the last 10% of data collected during the zero current pulse.  All experiments were 
conducted at room temperature (25°C) inside a Faraday cage. 
5.3 Results and Discussion 
5.3.1 Mechanistic Response 
Polyion selective pulstrodes were employed to monitor enzymatic activity using 
acid phosphatase and hexametaphosphate as a model system.  Measurements were made 
using a conventional three-electrode system (working, counter, reference) based on a 
three-pulse sequence: (1) the galvanostatic pulse, (2) an open-circuit period, and (3) the 
potentiostatic pulse.  The polymeric membrane within the working electrode is doped 
with a lipophilic ion-exchanger salt with no intrinsic ion-exchange properties.  However, 
during pulse 1, a 20 µA current is applied to the membrane for 1 s.  The current induces a 
flux of anionic species from the sample towards the membrane, and concomitantly 
	   77	  
polarizes the lipophilic salt species in the membrane phase.  During this pulse, the 
TDMA+ inside the membrane migrates to the sample/membrane interface.  Subsequently, 
the sample/membrane interface now has anion-exchange properties, and TDMA+ can 
exchange less preferred anionic background ions, such as Cl-, for the target analyte 
(hexametaphosphate) during the 0.5 s open circuit pulse (pulse 2).  Potentiometric data is 
acquired during pulse 2, where the last 10% of the cell EMF data is averaged and used as 
a single data point, which represents a single pulse sequence.  The reversibility of this 
sensor is dependent on pulse 3, where a 15 s, 0 V pulse depolarizes the membrane and 
expels target polyanion (hexametaphosphate) and background ions that were forced into 
the membrane during pulse 1.  The principles of this method have been reported by 
Bakker and co-workers11,12 and the functions of each of these steps have been described in 
prior work reported by Gemene et al.14 for polyanion sensing.   
The same principles for monitoring enzymatic activity with single-use polyion 
sensors can be used to understand the response observed in the pulstrode measurements.  
As the intact hexametaphosphate is digested, the smaller fragments that are produced 
make weaker cooperative ion-pairs with the ion-exchanger, which is observed in the 
reversal in signal towards baseline potentials.  A schematic of this process is shown in 
Figure 5.1. 
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Figure 5.1. Schematic of polyanion substrate degradation by enzyme.  (A) Separate measurement 
sensor responses to intact polyanion and digested polyanion.  Scales for the potentiograms are the 
same.  (B) Sensor response during an enzymatic reaction where the polyanion is added to a 
background solution and the enzyme is injected once the signal to the polyion is stable.  A reversal in 
signal is observed due to the digestion of the substrate.     	  
5.3.2 Hexametaphosphate Measurements 
Measurements were carried out using polyanion selective pulstrodes to measure 
activity of acid phosphatase when hexametaphosphate was present as the substrate.  All 
measurements were subtracted from background solution potentials (1 mM NaCl in 10 
mM MES buffer, pH 5.2).  The linear response range of the sensor towards 
hexametaphosphate was determined, and a concentration of 40 µg/mL, near the end of 
the linear response region (see Figure 5.2), was used throughout all experiments.  It is 
necessary to use a substrate concentration within this region so that enzyme activity could 
be easily observed.  For example, if the initial substrate concentration fell beyond the 
higher end of the linear range, the reversal in signal could not be seen immediately, and 
only when the enzyme digested enough of the substrate to decrease the concentration to 
one which fell within the linear range boundaries would a significant signal change be 
observed.  Since acid phosphatase loses significant activity at room temperature within 
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24 h,17 it is important that the reversal in signal is observed immediately so that the 
enzyme’s initial activity can be calculated accurately.  However, it is also important to 
choose a concentration within the linear range high enough to create a fairly large overall 
potential change when the pure substrate is measured, so that a significant reversal in 
signal can be observed when the enzyme is added and the rate of change can be easily 
calculated.  Therefore, subsequent enzyme activity measurements were made using 40 
µg/mL hexametaphosphate to ensure that the potential change to this concentration was 
stable and reproducible with an average potential change of -85.3 mV and standard 
deviation of 2.50 mV (n= 3).   
 
Figure 5.2. (A) Dynamic response and (B) calibration curve for hexametaphosphate in 1 mM NaCl, 
10 mM MES buffer.  For substrate digestion to be observed using pulstrode, a large concentration 
within the linear must be selected to monitor the enzymatic activity.  The concentration used in all 
experiments was 40 µg/mL hexametaphosphate.    
  
5.3.3 Digestion of Hexametaphosphate by Acid Phosphatase 
Different acid phosphatase concentrations were monitored using the polyion 
selective pulstrode.  During a typical measurement, background solution potentials were 
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measured first, for 10 pulse sequences, to establish a baseline potential.  Then 
background containing 40 µg/mL hexametaphosphate was recorded for 10 pulse 
sequences and the potential was subtracted from the baseline measurement to determine 
potential response to the substrate followed by a second background measurement to 
ensure the same baseline potential can be obtained before monitoring the substrate in the 
presence of enzyme.  For enzyme activity measurements, the substrate was added to 
solution and measured for three pulse sequences before enzyme was injected.  The total 
pulse sequence number was extended to 40 for these measurements, which were 
approximately 12 min from the point of enzyme injection (enzyme was injected after 3 
pulses which is ~52 s).  Experiments were carried out to determine the initial rate of 
reaction by measuring the decrease in substrate response in the presence of the enzyme 
for the first 12 min.  Once the enzyme was added to solution, a reversal in signal towards 
the baseline was immediately observed.  As shown in Figure 5.3A, the signal reversal 
increases at a faster rate as the enzyme activity increases, indicating the faster digestion 
of hexametaphosphate as acid phosphatase activity increases.  Enzyme activities of 0.15, 
0.25, 0.35, 0.5, and 0.75 U/mL were measured and rates were determined by calculating 
the slope of potential response vs. time during the first two minutes after enzyme 
injection (Figure 5.3B).   
Signal reversal rate vs. enzyme activity was plotted and a linear trend is observed 
for concentrations of 0.15 U/mL to 0.5 U/mL, as shown in Figure 5.4.     
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Figure 5.3. (A) Potentiometric data for enzyme activities of 0.15, 0.25, 0.35, 0.5, and 0.75 U/mL in 40 
µg/mL hexametaphosphate, 1 mM NaCl, 10 mM MES buffer.  (B) Enlarged graph of the first ~2 min 
of EMF vs. time curves after injection of 0.35 U/mL acid phosphatase activity. 	  
             
                      
Figure 5.4. Rate of potential change vs. acid phosphatase activity, where n=6.  All measurements 
were made in 40 µg/mL hexametaphosphate, 1 mM NaCl, 10 mM MES buffer, pH 5.2. 	  
Enzyme activity measurements for concentrations larger than 0.75 U/mL were 
conducted.  However, an instant sharp increase in signal was observed immediately after 
enzyme injection, which then tapered off into a slower reversal in signal.  This increase 
of the signal became larger as the enzyme concentrations increased and rates for these 
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concentrations could not be calculated due to the discontinuity in the data (see Figure 5.5 
as example).  Since data is only collected every 17.5 s, this may suggest that enzyme 
concentrations exceeding 0.75 U/mL are digesting the substrate too rapidly for the sensor 
to detect a continuous reversal in signal.   
                
Figure 5.5. Discontinuity in reversal in signal induced by 1 U/mL acid phosphatase in 40 µg/mL 
hexametaphosphate, 1 mM NaCl, and 10 mM MES buffer, pH 5.2.   	  
Intuitively, shortening the pulse sequence length could assist in extending the 
linear range.  Indeed, the potentiostatic pulse length has been reduced to 6 s without 
losing reproducibility in previous studies16 but, unfortunately, this did not alleviate the 
sharp break in the data observed in this work.  Obviously, diluting higher enzyme levels 
to achieve activities in the range where linear response to enzyme activity is observed is 
the simplest solution to this issue.   
5.3.4 Enzyme Inhibitors 
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The effect of an enzyme inhibitor on the hexametaphosphate/acid phosphatase 
system was also studied.  A proprietary blend of enzyme inhibitors, which contains 
sodium tartrate, a well-known competitive inhibitor of acid phosphatase,18 was diluted to 
a 1 v% solution and used for all measurements.  One acid phosphatase concentration, 
0.75 U/mL, was chosen to study enzyme inhibitor effects.  As expected, a decrease in 
acid phosphatase activity was observed in the presence of the inhibitor.  Solutions of 
0.00005, 0.0001, 0.00025, 0.0005, 0.001, 0.002, 0.003, 0.004, 0.005 and 0.01 v% were 
examined to determine the effect on acid phosphatase activity and are presented in Figure 
5.6.  Fairly good linearity is observed between 0 and 0.00025 v% inhibitor solution 
before enzyme activity begins to level off at an extremely low level.  Zero enzyme 
activity is finally reached when 0.1 v% solution of inhibitor is present. 
                
Figure 5.6. Effect of inhibitor concentration on acid phosphatase activity at 0.75 U/mL.  The inset 
shows the linearity of data points between 0 and 0.00025% inhibitor solution.   	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5.4 Conclusions 
A polyanion sensitive pulstrode has been successfully employed for monitoring 
acid phosphatase activity using hexametaphosphate as the substrate.  ISEs, in general, 
provide a simple method for measuring enzyme activities in complex and turbid solutions 
that is stable and selective.  Single-use polyion sensors have been utilized previously to 
determine enzyme activities, but their irreversible nature prevents multiple uses, which 
can be inconvenient when measuring many different samples.  Thus, the pulstrode 
provides a stable and reproducible measurement system that can be employed for several 
assays without requiring many different sensors to determine enzyme activity in many 
samples.  Although it may be necessary to optimize measurement conditions for different 
substrate/enzyme systems based on the given enzyme activity or sensor response to the 
polyion substrate, it is likely that the approach reported here could be utilized to detect 
the degradation of other substrates for acid phosphatase, such as diadenosine 
pentaphosphate and polyadenylic acid, or enzymes such as heparinase I, II, and III 
activity, which are known to cleave polyanionic heparin into small fragments. 
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CHAPTER 6 
POLYION SELECTIVE POLYMERIC MEMBRANE-BASED PULSTRODE FOR 
THE DETECTION OF HIGH CHARGE DENSITY SPECIES 
IN HEPARIN PREPARATIONS 	  
6.1 Introduction 
 The efficacy of single-use polymeric polyion sensors for the detection of high 
charge density contaminants (i.e., OSCS) was examined and demonstrated in Chapter 3.  
These sensors have viability for screening commercially available heparin preparations 
that is cost effective, easy to use, and reliable, with detection limits (≥ 0.5 wt%),1 well 
below the level of toxicity of OSCS in heparin (5 wt%).2  A single use, hand held strip 
test device based on the principles of the single-use heparin sensor has recently been 
developed, and even lower detection limits of 0.005% OSCS in heparin preparations have 
been reported.3 Although these qualities make these sensors desirable for heparin 
screening, their irreversible nature limits applications in clinical settings, such as in-line 
monitoring during heparin administration.  In recent years, reversible non-equilibrium 
sensor applications have been pursued to improve and modify selectivity and to improve 
detection of large polyions like heparin and protamine.4-11  Hence, a reversible detection 
method for high charge density (HCD) species in heparin should be pursued to extend the 
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applications in which polyion sensors can be useful to rule out contamination and/or 
tainting of commercial heparin products. 
 As discussed in Chapters 4 and 5, the polyion pulstrode device has addressed the 
irreversible quality of single-use polyion sensors by providing a system in which the 
membrane is renewed after each measurement of heparin or other polyions.  Therefore, in 
this chapter, the optimization of this system for improving detection limits of HCD 
species in heparin preparations is pursued.   The charge density of pentosan polysulfate 
(PPS) is much larger than heparin,12,13 and this species is therefore useful as a model HCD 
species spiked into heparin preparations.  Optimization of the current magnitude, length 
of the current pulse, and length of the zero-current, open-circuit pulse is carried out and 
the impact on detection limits of the PPS in heparin is demonstrated and discussed.   
6.2 Experimental Section 
6.2.1 Reagents 
High molecular weight poly(vinyl chloride) (PVC), 2-nitrophenyloctyl ether (o-
NPOE), tridodecylmethylammonium chloride (TDMACl), anhydrous tetrahydrofuran 
(THF), heparin sodium salt, and all buffer salts were purchased from Sigma Aldrich (St. 
Louis, MO).  Pentosan polysulfate (PPS) was obtained from Bene Arzneimittel GmbH 
(Munich, Germany).  Dinonylnaphthalene sulfonic acid (DNNSH) as a 49% solution in 
xylenes was a gift from King Industries (Norwalk, CT). 
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6.2.2 Preparation of Ion-Exchanger Salts 
 The lipophilic ion-exchanger salt used in the polymeric membrane was prepared 
by metathesis in benzene for a 1:1 molar ratio of DNNSH and TDMACl.  The benzene-
salt solution was washed several times with Milli-Q grade deionized water (18.2 Ω, 
Millipore Corp., Billerica, MA) until the aqueous solution was neutral.  The benzene 
phase was then left to dry overnight (in open air in a fume hood), and the residual salt 
was re-dissolved in THF and then dried again overnight for use in preparation of the 
polyion selective membranes. 
6.2.3 Polymeric Membrane Preparation 
 All polyion selective membrane films contained 10 wt% of TDMA/DNNS salt 
and were ~200 µm thick.  The sensing membranes were all formulated to contain a 1:2 by 
weight ratio of PVC to o-NPOE plasticizer.  All membrane components were dissolved in 
THF and membrane films were prepared by solvent casting solutions into glass rings on 
glass plates and letting the solutions dry overnight (in fume hood).  
6.2.4 Electrodes 
 Sensor membranes were cut with a cork borer (8 mm diam.) from the parent 
membrane and placed into an electrode body (Oesch Sensor Technology, Sargans, 
Switzerland).  The actual membrane area was 20 mm2.  All sensors were conditioned 
overnight in 1 mM NaCl, 10 mM phosphate buffer, pH 7.4.  The inner-filling solution in 
contact with the inner Ag/AgCl reference was the same as the outer conditioning 
solution.  A double-junction Ag/AgCl electrode with 3 M KCl as the inner filling solution 
and 1 M LiOAc as a bridge electrolyte was used as the external reference electrode.  A 
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coiled Pt-wire was used as a counter electrode for all pulsed chronopotentiometric 
measurements. 
6.2.5 Measurements Using Polymeric Membrane Configuration 
 A conventional three-electrode set-up was used for the pulstrode measurements 
with the TDMA/DNNS-based polymeric membrane electrode serving as the working 
electrode and all electrodes were immersed in background/sample solutions.  All 
experiments were carried out in 1 mM NaCl, 10 mM phosphate buffer, pH 7.4.  The 
electrochemical measurements were conducted with an AFCBI bipotentiostat (Pine 
Instruments, Grove City, PA) controlled by a NI-DAQPad 6015 interface board and 
LabVIEW 8.6 data acquisition software (National Instruments, Austin, TX) on a PC 
computer.  All measurements were carried out inside a Faraday cage to minimize 
electronic noise.  Current (galvanostatic) pulse times of 1, 2, 3, 4, and 5 s and current 
magnitudes from 10-35 µA were used for optimization experiments.  Zero-current pulse 
lengths of 0.5, 1, 2, 5, and 10 s and a potentiostatic pulse of 0 V vs. Ag/AgCl (stripping 
potential) of 15 s were used.  The potentials were sampled as the averaged data during the 
last 10% time period of the 0.5 s zero-current pulse.   All experiments were carried out at 
room temperature (21-23 ˚C). 
6.3 Results and Discussion 
 The initial parameters used for pulstrode experiments to detect PPS in heparin 
preparations are as follows: a 1 s, 20 µA current pulse, a 0.5 s zero-current open-circuit 
pulse, and a 15 s 0 V potentiostatic pulse.  Overall potential responses for pure heparin 
and pure PPS at 400 µg/mL in 1 mM NaCl, 10 mM phosphate buffer, pH 7.4, were ~-100 
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mV and ~-220 mV, respectively.  Assuming a linear response to PPS, the detection limit 
for 10 wt % PPS spiked into 400 µg/mL heparin under the above-mentioned conditions 
should be 0.6 wt% PPS.  Limits of detection were calculated solving the following 
equation for X: 3 x s.d. = mX, where s.d. is standard deviation of the signal to pure 
heparin, m is the slope/sensitivity of signal vs. concentration of PPS contaminant, and X 
is the concentration.  However, this method was not ultimately used to obtain the “true” 
LOD for PPS in heparin since as the concentrations of PPS decrease in heparin 
preparations, the degree of EMF difference between pure heparin and the contaminated 
sample does not have a linear dependence.  Rather, the response to very low levels of 
PPS in the heparin is not actually discernible from the pure heparin signal, until a critical 
concentration of PPS is reached, at which point there is a clear difference in the EMF 
values for the pure heparin vs. the PPS contaminated heparin (see Fig. 6.1).   
                 
Figure 6.1. Potentiometric data for 5 (black asterisk), 4 (red asterisk), 3 (blue asterisk), 2 (green 
asterisk), and 1 wt% (purple asterisk) PPS in 400 µg/mL heparin, 1 mM NaCl, 10 mM phosphate 
buffer.  A 1 s, 10 µA current pulse, 0.5 s open-circuit pulse, and 15 s potentiostatic pulse was applied.     	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Figure 6.2 displays the change in detection limits as the PPS concentration within 
400 µg/mL heparin increases.  Detection limits calculated for 5 wt% PPS in heparin are 
half that calculated for 1%.  This is likely due to the kinetic limitation of the pulstrode 
system (see below).  	  	  	  
                      
Figure 6.2. Detection limits for 1, 2, 3, 4 and 5 wt% PPS in heparin preparations.  A 1 s, 10 µA 
current pulse, 0.5 s open-circuit pulse, and 15 s potentiostatic pulse was applied.  At 5 wt% PPS, the 
detection limits are half of what has been calculated for 1 wt%.  No linearity is observed. 	  
Pulstrode measurements of PPS concentrations ≥ 10 wt% in heparin gave 
intermediate (mixed) potential responses (see Figure 6.3).  This is in contrast to the 
potential change observed during a simultaneous measurement of two different 
polyanions in single-use sensors, where the potential response is essentially governed by 
the polyion with the largest charge density at ≥ 5 wt%.1  Typical reproducibility data for 
the measurement of pure heparin and 10 wt% PPS in heparin preparations using the 
pulstrode can be seen in Figure 6.3.   
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Figure 6.3. Response to heparin and heparin spiked with PPS.  Measurements for 400 µg/mL heparin 
followed by heparin spiked with 10 wt% PPS (annotated with *), where pulse sequence was a 1 s, 20 
µA current pulse, a 0.5 s open-circuit pulse, and a 15 s, 0 V potentiostatic pulse.  Averages and 
standard deviations of measurements for heparin and 10 wt% PPS are -97.0 and ±0.693 mV, and -
106 and ±0.873 mV, respectively.  The average difference between pure heparin and PPS spiked 
heparin is -8.67 mV with standard deviation of ±0.473 mV.   	  
As mentioned above, the difference in sensor behavior with higher concentrations 
of PPS in the heparin is due to the kinetics.  The current pulse induces an ionic flux, 
driving all analytes with a complimentary charge toward and into the membrane.4-6  It is 
not until the open-circuit pulse phase that the ion-exchanger in the sensing membrane can 
exchange less preferred analytes for the contaminant/target analyte (thermodynamics of 
cooperative ion pairing favors analytes with larger charge densities; in this case, heparin 
< PPS).  The 0.5 s length of this pulse may not allow enough time for the ion-exchanger 
to completely exchange heparin for PPS before it is expelled back into the sample 
solution by the regenerative potentiostatic pulse.  In single-use experiments, where 
concentrations of HCD species < 5 wt% can be readily detected, a potential drift down to 
the characteristic equilibrium EMF response is observed.1  However, the time the sensor 
is allowed to equilibrate after injection of the polyion mixture is ~10 min.  Therefore, 
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experiments were carried out to extend the time length of the open-circuit pulse when 
using the pulstrode to assess whether better detection limits for PPS in heparin could be 
achieved.  Time lengths of 1, 2, 5 and 10 s were studied, but results were not 
reproducible.  For typical measurements with the 0.5 s open-circuit pulse, potentials are 
reproducible, and standard deviations are only 0.7% of the overall signal.  However, with 
time periods longer than 0.5 s, the potentials generated exhibit relative standard 
deviations as large as 12% of the potentiometric signal.  Measurements for all time 
periods can be seen in Figure 6.4. 
        
Figure 6.4. Potential changes associated with different time lengths of open-circuit measurements.  
Each point represents the average potential change for a given time length.  For the above points, 
standard deviations are as follows: (0.5 s) 0.515 mV, (1 s) 6.15 mV, (2 s) 2.62 mV, (5 s) 9.62 mV, and 
(10 s) 6.02 mV.  A 1 s, 15 µA current pulse and a 15 s potentiostatic pulse were applied.    	  
 An explanation for this behavior may be clarified by studies reported by Lindner 
and co-workers.14  The restoration of uniform equilibrium concentration profiles in 
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polyion sensing membranes is absolutely necessary if the sensor is intended to exhibit 
fully reversible and reproducible EMF functionality.  The simplest restoration method is 
open-circuit zero-current relaxation, which is a diffusion-controlled process.  Studies 
were carried out by Lindner and co-workers to determine the ideal method of membrane 
restoration in current-controlled membrane-based sensor systems.  It was found that a 
minimum of 90 min was required for the open-circuit restoration method to obtain 
reproducible measurements,14 and this is likely because the zero-current relaxation 
process following an applied current is very slow for most ISEs.15  Hence, a reverse 
current was applied to speed up the restoration process (in contrast to studies carried out 
by Bakker and co-workers,4-6 where a voltage pulse is used to restore the initial 
membrane composition).  The 0.5 s time length of the open-circuit pulse is short enough 
to measure the sample/membrane interface potential reproducibly since any change in 
concentration profile within the 0.5 s is negligible.    
Other factors were also taken into consideration regarding the membrane 
concentration profile during the current pulse.  Hypothetically, the current pulse may not 
be sufficient in polarizing the lipophilic ion-exchanger salt within the membrane.  By 
increasing the length of time of the current pulse, it was thought that increasing the 
concentration of ion-exchanger at the sample/membrane interface (see Figure 6.5) would 
increase the number of cooperative ion-pairs made at the surface.  Therefore, 
optimization of the length of time for the current pulse was also pursued.  All 
experiments were compared to results obtained using a 1 s 20 µA current pulse.  Other 
pulse lengths studied were 2, 3, 4 and 5 s.  However, no detection limit improvement for 
HCD species was observed in comparison to results obtained in Figure 1.  It is likely that 
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any improved polarization induced by increasing the time length of the current pulse was 
negligible. 
                            
Figure 6.5. Membrane concentration profile scheme.  As current polarizes the membrane, the 
concentration of salt components increase at opposite interfaces of the membrane.  The purple and 
green traces represent TDMA+ and DNNS-, respectively, migrating towards the opposite interfaces.  
The red and blue lines represent TDMA+ and DNNS- at their final concentrations, just before the 
open-circuit zero-current pulse is applied. 	  
 The applied current magnitude can also be used to control the concentration of 
target analyte measured in pulstrode experiments,4-6 and for that reason, optimizing the 
magnitude of current was also pursued.  Intuitively, one would consider increasing the 
current magnitude to increase the concentration of the target HCD species within the 
membrane to improve detection limits for the HCD in heparin preparations.  However, 
the literature suggests that lower current magnitudes are more beneficial in improving 
selectivity.6,7  In addition, larger current magnitudes can destroy the membrane by 
permanently expelling portions of the lipophilic ion-exchanger salt.  This is undesirable 
because the salt integrity (maintaining the 1:1 molar ratio of the TDMA/DNNS) is 
critically important to obtain reproducible EMF measurements.  All experiments were 
compared to results obtained using a 1 s, 20 µA current pulse and a 0.5 s open-circuit 
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pulse.  Current magnitudes of 5, 10, 15, 25, 30, and 35 µA were used to determine the 
optimal parameter.  Note that the overall potential change to heparin increases as the 
current magnitude increases.  However, detection limits of PPS in heparin do not improve 
when larger currents are applied.  The optimal current magnitude was found to be 10 µA, 
where a statistical significant difference was calculated at 2 wt% PPS (3 mV difference 
between heparin and heparin contaminated with 2 wt% PPS, Figure 6.1).  However, in 
order for this method to have in-line applications, it would be desirable to have a larger 
potential difference.  For example, a 3 mV shift in baseline may not be able to be 
differentiated from typical baseline drift if the pulstrode were used for in-line 
measurements during procedures that involve heparinization.  Otherwise, special 
software would be needed to detect these smaller changes.  Heparin preparations 
containing 4 and 5 wt% PPS gave signals that could be easily distinguished, with similar 
overall potential differences (subtracted from potentials of pure heparin) of -7 and -10 
mV respectively.  The results for heparin contaminated with 5 wt% PPS can be seen in 
Figure 6.6.   
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Figure 6.6. The dynamic response for 1 s 10 µA current measurements for heparin and heparin 
samples spiked with 5 wt% PPS.  Measurements of heparin spiked with 5% PPS are noted with 
asterisks (*).    	  
The potential change observed for 10 wt% PPS in heparin also increased (see 
Table 1), in comparison to other current magnitudes studied.  Severe drift was observed 
for a current magnitude of 5 µA, suggesting that the current magnitude is too low to 
maintain a stable baseline.     
Table 6.1. Average potential change for heparin (0% PPS), 10 wt% PPS in heparin, and the average 
potential difference between the two measurements.  For all measurements, n=3, except for 10 and 20 
µA, where n=7.  The blue highlighted data represents the ideal current magnitude for detection of 
high charge density species (PPS) in heparin preparations with polymeric membrane compositions.  
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6.4 Conclusions 
Single-use polyion sensors for the detection of high charge density contaminants 
have exceptional detection limits, where as little as 0.5 wt% of contaminant can be 
detected in heparin preparations.1  Although the pulstrode configuration is not yet capable 
of such low detection limits, the reversible nature of the sensor would be much more 
desirable, especially as a commercial product.  The pulstrode could potentially be used as 
an in-line system to monitor heparin during continuous infusion of heparin into a patient 
via a heparin drip line.  Such a system could provide an alarm type system to alert 
medical personnel that some high charged contaminant is present in the heparin being 
given to the patient.  
Further optimization of the pulstrode sensor for this application includes 
reformulating the membrane and improving polyanion detection in physiological NaCl 
levels, which is still an obstacle for the current pulstrode set-up.  These ideas are 
discussed in more detail in Chapter 7.       
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CHAPTER 7 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
7.1 Summary of Results and Contributions 
 Ion-selective electrodes (ISEs) have become important analytical tools for the 
detection and quantification of biomedically relevant ions due to their sensitivity, 
selectivity, and accuracy in measuring ion activities/concentrations.  Although it was not 
considered possible to create ISEs for polyion detection, the breakthrough development 
of the single-use polymeric polyion selective (heparin) sensor opened the door to their 
application to many different biomedically important measurements.1-6  The most  notable 
being the quantitation of heparin in whole blood1-4 and the detection of the 
contaminant/adulterant OSCS in commercially available heparins.5  While the heparin 
sensor has been successfully applied in a variety of polyanion measurement applications, 
the reversible polyion selective pulstrode sensor was developed to address the irreversible 
nature of this single-use sensor.  In addition, the pulstrode has provided a means to detect 
both polyanions and polycations with the same sensor/membrane device and has inspired 
a significant fraction of the research described in this dissertation.   
 In Chapter 2, a re-investigation into the working mechanism of the heparin sensor 
was initiated, and sufficient experimental evidence supports the previously reported 
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polyanion extraction mechanism.3,7  Transport experiments were conducted using 
diffusion cells and varying polymeric membrane thicknesses, and diffusion coefficients 
of heparin within the polymeric membranes were calculated using equation 5 from 
Chapter 2 and determined to be reproducible.  To verify this experiment, impedance 
spectroscopy was also carried out to determine the membrane conductivity, and as 
predicted, conductivity decreased as the target analyte migrated deeper into the sensing 
membrane.  Gel electrophoresis was also employed to examine the polydispersity of low 
molecular weight heparin (enoxaparin), unfractionated heparin, and fractionated heparin.  
Based on the literature,8 unfractionated heparin is void of LMW heparin species, and this 
was confirmed by the electrophoresis experiment.   
 In Chapter 3, the utility of the heparin sensor to detect OSCS in commercially 
available heparin preparations was evaluated.  A blind study was carried out and heparin 
sensors were employed in screening a number of commercial heparin lots for OSCS that 
were provided by Baxter, Inc.  After measurements were tallied, Baxter provided the 
relevant NMR data, which provided information regarding which samples were truly 
contaminated and the quantities of OSCS in each.  As reported in Chapter 3, 100% of the 
sample measurements made with heparin sensors correlated with NMR data provided by 
Baxter, Inc.  These sensor measurements did not provide any quantitative information, 
since in all cases the EMF change that was observed immediately went to the 
equilibrium/maximum value obtained for pure OSCS.  However, such measurements can 
be readily used to determine qualitatively whether a sample is contaminated or not.  
Quantitative studies have been reported using the single-use sensor, but such experiments 
involve diluting heparin samples so the OSCS contaminant does not immediately induce 
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the equilibrium response.  The rate of the EMF drift towards the larger EMF change for 
OSCS provides quantitative information for the contaminant.6   
 In Chapter 4, the use of a polyion selective pulstrode as a detector for FIA was 
explored and measurements were proven to be stable and reproducible.  A thorough 
investigation into the longevity of the membrane composition within the flow-mode was 
carried out, and it was found that the leaching of the lipophilic cation-exchanger salt 
component (DNNS-) was exacerbated by the constantly flowing the solution.  
Measurements made in static mode are stable for longer time periods; however, the 
pulstrode-FIA system has higher throughput capabilities.  Five measurements per hour 
can be made in static mode, whereas the pulstrode-FIA was optimized to measure up to 
twenty samples per hour.  Protamine was measured, heparin was titrated into the solution, 
and a decrease in sensor response to protamine was observed, suggesting that this FIA 
system could be used to detect heparin levels in a variety of samples. 
 In Chapter 5, the pulstrode was employed in monitoring polyanions/enzymatic 
activity degradation, where hexametaphosphate (substrate) and acid phosphatase 
(enzyme) were used as a model system.  The EMF signal for the substrate was measured 
and enzyme was then added to the sample solution in which the pulstrode was placed in 
the polyanion sensing mode.  A drift in potential towards the original baseline (in pure 
buffer) was observed and indicated substrate degradation by the enzyme.  Reaction rates 
were calculated by measuring the slope of the EMF change during the first two minutes 
after enzyme injection.  As expected, an increase in rate correlated with an increase in 
enzyme activity.  Measurements were also made 24 h after the addition of enzyme to the 
substrate solution.  No change in potential was observed when measurements of the 
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substrate-enzyme solution were subtracted from baselines generated by background 
buffer, indicating full the substrate degradation.  In addition, studies were carried out to 
determine the effect of enzyme inhibitor (sodium tartrate) on acid phosphatase.  As 
expected, a decrease in enzymatic activity rate was observed in proportion to the level of 
inhibitor present.       
 In Chapter 6, the polyion pulstrode system parameters were optimized for 
detection of high charge density contaminants in heparin preparations.  Although 
detection limits of high charge density species in heparin with this system are not as low 
as those reported for the single-use polyion sensor, an overall improvement of the LOD 
for detecting PPS as a model polyanion impurity in heparin was achieved with the 
optimal parameters yielding a detection limit of 2 wt% PPS.  
7.2 Future Directions 
In Chapter 3, the efficacy of the heparin sensor for the detection of OSCS was 
examined and a 100% correlation with NMR data provided by Baxter, Inc. was 
determined.  The development of a commercial device for bench-top screening of 
commercially available heparin would be an obvious direction for this project.  Recently, 
a single-use electrochemical strip-test device based on the principles of the heparin sensor 
has been developed and reported by Cha and co-workers,9 but commercialization of this 
product has not yet been pursued. 
Other applications for the single-use sensor include detection of fucoidan (Figure 
7.1), a highly sulfated polysaccharide harvested from several species of brown 
seaweed,10,11 which may have anti-inflammatory properties,12 and may relieve pain 
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caused by osteoarthritis,13 along with many additional medicinal applications.14-17  Since 
there are both linear and branched structural variations and differing degrees of sulfation 
of fucoidan species,10,11 it is important to have easy and cost-effective techniques to 
distinguish between the different variations so that further research can be pursued in 
determining the specific medicinal uses of each fucoidan variant.  Extensive studies have 
been conducted by Prof. Kelly Mowery’s group at Eastern University (Prof. Mowery is a 
former member of the Meyerhoff group), which yielded successful and comparable 
results with single-use polyanion sensors.  Therefore, the reversible pulstrode technique 
may also have applications in fucoidan detection, and such pulstrode experiments should 
be carried out regarding the detection of this important high charge density 
polysaccharide.         
                	  
Figure 7.1.  Examples of structures of linear and branched fucoidans found in brown seaweed.  (A) 
Linear fucoidan harvested from fucus evanescens (species of brown seaweed) and (B) branched 
fucoidan harvested from chorda filum (species of brown seaweed).   
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Results reported in Chapter 4 suggest that there may be applications for 
monitoring protamine and heparin in whole blood using an FIA system.  Preliminary 
experiments in whole blood have been carried out, but large background EMF changes 
prevented protamine peaks from being distinguished.  One approach to improving 
protamine detection in whole blood when using the pulstrode as a detector in FIA would 
be to decrease the current pulse magnitude.  Successful protamine detection in whole 
blood has been reported by Bakker and co-workers in static mode.18,19  In these 
experiments,19 a -2 µA current was used to induce the ion flux and polarize the 
membrane.  This smaller current magnitude may be key in reducing the large background 
response (physiological matrix).  Therefore, optimization of current magnitudes < -12 µA 
should be pursued to achieve detection of protamine in whole blood samples using the 
FIA pulstrode arrangement.  If significant EMF changes can be observed, then indirect 
detection of heparin levels in whole blood would be possible using a reagent stream of 
protamine at a fixed concentration to merge with the sample stream consisting of the 
injected whole blood sample.   
Other potential pulstrode-FIA applications include additional studies of enzymatic 
reactions in the flow mode.  Some preliminary experiments have been carried out using 
trypsin and protamine as a model system and have been successful (see Chapter 4).  
Slight modifications were made to the pulstrode-FIA system.  Two carrier streams were 
employed: one containing protamine, and the other the background buffer, while the 
protamine concentration was held constant throughout.  Different concentrations of 
trypsin were injected into the sample port, and both streams met at a mixing triangle.  For 
increasing trypsin activity, an increasing inverted peak deviation from the protamine 
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baseline was observed.  This set-up provides rapid measurements for enzyme assays, and 
additional studies should be carried out regarding alternate enzymatic systems (e.g., 
heparin/heparinase and DNA/DNases). 
 The higher sample throughput of the pulstrode-FIA method could also be 
improved by further reducing the length (time) of the potentiostatic pulse (described in 
detail in Chapter 4).  The potentiostatic pulse must be sufficient in completely restoring 
the membrane back to its initial state in order to obtain reproducible EMF measurements.  
Therefore, reformulating the membrane to improve diffusion/ion mobility rates within the 
membrane phase could allow for even shorter potentiostatic pulse times, leading to an 
increase in the overall samples per hour measured (in comparison to the 20 samples/h 
reported in Chapter 4).  A newer membrane formulation pioneered by Bakker and co-
workers (discussed in Chapter 1) may provide enhanced membrane diffusion coefficients.  
The membrane is fabricated by impregnating the pores of a 25 µm thick, porous 
polypropylene film with plasticizer doped with an ion-exchanger salt.  This membrane is 
more fluid-like in comparison to the plasticized polymeric membrane used for pulstrode 
studies in this dissertation.  Hence, diffusion coefficients and mobility of ions within such 
membranes should be much more rapid.  With this newer membrane formulation, it may 
be possible to restore the initial ion concentration profiles more quickly and to further 
decrease the potentiostatic pulse length.   
 Reformulating the membrane, mentioned above, may also have an impact on 
monitoring enzymatic reactions in static mode as well.  In Chapter 5, the pulstrode was 
not capable of monitoring enzymatic activity above 0.75 U/mL due to signal 
discontinuity.  If the pulse sequence (17.5 s) can be shortened (minimizing time length of 
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potentiostatic pulse), it may be possible to diminish the signal discontinuity and expand 
the enzyme activity range the sensor can measure.    
 Another shortfall of the pulstrode system is that polyanions could not be measured 
in physiological NaCl background (i.e., 0.1 M NaCl).  In contrast to results reported for 
protamine in whole blood,18,19 heparin has yet to be detected in physiological matrices, 
even at large concentrations (> 400 µg/mL).  Recently, improved detection limits for 
protamine in physiological background were reported.20  Chronopotentiometric 
measurements employing a 2:1 DNNS/TDDA ion-exchanger salt doped into a thin 
porous polypropylene membrane allowed for a lower LOD.  The Bakker group carried 
out such experiments for direct heparin detection.  However, these experiments were 
unsuccessful.  It was hypothesized that the energy output from the potentiostatic pulse 
(for membrane regeneration) was too weak to reverse the cooperative ion-pair formed by 
heparin and TDMA+.  The protamine/DNNS complex is much weaker than the 
heparin/TDMA complex, simply because the absolute value of charge density for 
protamine is much smaller than heparin (20 vs. 70).  In addition, smaller polyions are less 
thermodynamically preferred by the ion-exchanger (e.g., protamine is actually much 
shorter in length than heparin).  Therefore, the 2:1 DNNS/TDDA doped membrane 
system was more successful in directly measuring protamine, since the potentiostatic 
pulse more easily regenerates initial membrane concentration profiles.   
Various ion-exchangers were evaluated during the development of the single-use 
heparin sensor.  Polymeric membranes doped with TDMACl gave the best responses, and 
this was likely because heparin forms the strongest cooperative ion-pair with TDMA+.1  
However, several ion-exchangers gave mid-range EMF responses to heparin in phosphate 
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buffered saline.  These responses may have resulted from weaker ion-pairing with 
heparin.  This weaker ion-exchanger/heparin complex is desirable for 
chronopotentiometric measurements so that the energy provided by the regenerative 
potentiostatic pulse is sufficient to reverse the cooperative ion-pair.  A membrane 
formulation containing a cationic ion-exchanger other than TDMA+, in 100% molar 
excess to DNNS-, may improve heparin detection limits in physiological matrices, such 
as whole blood.  This opens the door also for improving the pulstrode approach for the 
detection of HCD contaminants in heparin preparations.  With this new membrane 
formulation, it may be possible to attain detection limits for 
pulstrode/chronopotentiometry as low as ones for single-use polyion sensors.  This sensor 
would also improve the likelihood that the pulstrode could be used as an in-line monitor 
for clinical applications. 
Lastly, miniaturizing the pulstrode may have the added benefit of measuring 
smaller sample sizes.  Currently, static mode pulstrode measurements are carried out in 
10 mL sample sizes.  Miniaturizing the sensor size and the double junction reference 
electrode could enable new applications, such as detection in microfluidic devices, etc.   
Of course, smaller area electrodes, such as micro ion-selective polymer membrane 
electrodes21,22 might be employed to achieve this goal, although with the much smaller 
membrane surface area comes much higher resistance, which could complicate things, 
but this may be overcome by reducing the membrane resistance (as mentioned above, 
e.g., using more liquid membranes).21,23 
Overall, new fundamental and applied studies of both single-use and reversible 
pulstrode type polyion sensors have been reported in this dissertation.  These devices 
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provide stable and reproducible EMF measurements proportional to polyion 
concentrations.  The field of polyion detection regarding potentiometric and 
chronopotentiometric (pulstrode) techniques has many potential biomedical/clinical and 
analytical applications.  With more development and optimization, commercial products 
based on this technology may be possible and will provide industry and clinicians with 
convenient, rapid, and cost-effective means to measure/monitor important polyions.  
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